1
|
Viana D, Walston ST, Masvidal-Codina E, Illa X, Rodríguez-Meana B, Del Valle J, Hayward A, Dodd A, Loret T, Prats-Alfonso E, de la Oliva N, Palma M, Del Corro E, Del Pilar Bernicola M, Rodríguez-Lucas E, Gener T, de la Cruz JM, Torres-Miranda M, Duvan FT, Ria N, Sperling J, Martí-Sánchez S, Spadaro MC, Hébert C, Savage S, Arbiol J, Guimerà-Brunet A, Puig MV, Yvert B, Navarro X, Kostarelos K, Garrido JA. Nanoporous graphene-based thin-film microelectrodes for in vivo high-resolution neural recording and stimulation. Nat Nanotechnol 2024; 19:514-523. [PMID: 38212522 PMCID: PMC11026161 DOI: 10.1038/s41565-023-01570-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/24/2023] [Accepted: 11/07/2023] [Indexed: 01/13/2024]
Abstract
One of the critical factors determining the performance of neural interfaces is the electrode material used to establish electrical communication with the neural tissue, which needs to meet strict electrical, electrochemical, mechanical, biological and microfabrication compatibility requirements. This work presents a nanoporous graphene-based thin-film technology and its engineering to form flexible neural interfaces. The developed technology allows the fabrication of small microelectrodes (25 µm diameter) while achieving low impedance (∼25 kΩ) and high charge injection (3-5 mC cm-2). In vivo brain recording performance assessed in rodents reveals high-fidelity recordings (signal-to-noise ratio >10 dB for local field potentials), while stimulation performance assessed with an intrafascicular implant demonstrates low current thresholds (<100 µA) and high selectivity (>0.8) for activating subsets of axons within the rat sciatic nerve innervating tibialis anterior and plantar interosseous muscles. Furthermore, the tissue biocompatibility of the devices was validated by chronic epicortical (12 week) and intraneural (8 week) implantation. This work describes a graphene-based thin-film microelectrode technology and demonstrates its potential for high-precision and high-resolution neural interfacing.
Collapse
Affiliation(s)
- Damià Viana
- Catalan Institute of Nanoscience and Nanotechnology (ICN2), CSIC and BIST, Campus UAB, Barcelona, Spain
| | - Steven T Walston
- Catalan Institute of Nanoscience and Nanotechnology (ICN2), CSIC and BIST, Campus UAB, Barcelona, Spain
| | - Eduard Masvidal-Codina
- Catalan Institute of Nanoscience and Nanotechnology (ICN2), CSIC and BIST, Campus UAB, Barcelona, Spain
| | - Xavi Illa
- Institut de Microelectrònica de Barcelona, IMB-CNM (CSIC), Campus UAB, Bellaterra, Spain
- Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina, Instituto de Salud Carlos III, Madrid, Spain
| | - Bruno Rodríguez-Meana
- Institute of Neurosciences, Department of Cell Biology, Physiology and Immunology, Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Universitat Autònoma de Barcelona, Barcelona, Spain
| | - Jaume Del Valle
- Institute of Neurosciences, Department of Cell Biology, Physiology and Immunology, Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Universitat Autònoma de Barcelona, Barcelona, Spain
- Secció de Fisiologia, Department de Bioquímica i Fisiologia, Facultat de Farmàcia i Ciències de l'Alimentació, Institut de Neurociències, Universitat de Barcelona, Barcelona, Spain
| | - Andrew Hayward
- Nanomedicine Lab, National Graphene Institute and Faculty of Biology, Medicine & Health, Manchester, UK
| | - Abbie Dodd
- Nanomedicine Lab, National Graphene Institute and Faculty of Biology, Medicine & Health, Manchester, UK
| | - Thomas Loret
- Nanomedicine Lab, National Graphene Institute and Faculty of Biology, Medicine & Health, Manchester, UK
| | - Elisabet Prats-Alfonso
- Institut de Microelectrònica de Barcelona, IMB-CNM (CSIC), Campus UAB, Bellaterra, Spain
- Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina, Instituto de Salud Carlos III, Madrid, Spain
| | - Natàlia de la Oliva
- Institute of Neurosciences, Department of Cell Biology, Physiology and Immunology, Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Universitat Autònoma de Barcelona, Barcelona, Spain
| | - Marie Palma
- Univ. Grenoble Alpes, Inserm, U1216, Grenoble Institut Neurosciences, Grenoble, France
| | - Elena Del Corro
- Catalan Institute of Nanoscience and Nanotechnology (ICN2), CSIC and BIST, Campus UAB, Barcelona, Spain
| | - María Del Pilar Bernicola
- Catalan Institute of Nanoscience and Nanotechnology (ICN2), CSIC and BIST, Campus UAB, Barcelona, Spain
| | - Elisa Rodríguez-Lucas
- Catalan Institute of Nanoscience and Nanotechnology (ICN2), CSIC and BIST, Campus UAB, Barcelona, Spain
- Hospital del Mar Research Institute, Barcelona, Spain
| | - Thomas Gener
- Catalan Institute of Nanoscience and Nanotechnology (ICN2), CSIC and BIST, Campus UAB, Barcelona, Spain
- Hospital del Mar Research Institute, Barcelona, Spain
| | - Jose Manuel de la Cruz
- Catalan Institute of Nanoscience and Nanotechnology (ICN2), CSIC and BIST, Campus UAB, Barcelona, Spain
| | - Miguel Torres-Miranda
- Catalan Institute of Nanoscience and Nanotechnology (ICN2), CSIC and BIST, Campus UAB, Barcelona, Spain
| | - Fikret Taygun Duvan
- Catalan Institute of Nanoscience and Nanotechnology (ICN2), CSIC and BIST, Campus UAB, Barcelona, Spain
| | - Nicola Ria
- Catalan Institute of Nanoscience and Nanotechnology (ICN2), CSIC and BIST, Campus UAB, Barcelona, Spain
| | - Justin Sperling
- Catalan Institute of Nanoscience and Nanotechnology (ICN2), CSIC and BIST, Campus UAB, Barcelona, Spain
| | - Sara Martí-Sánchez
- Catalan Institute of Nanoscience and Nanotechnology (ICN2), CSIC and BIST, Campus UAB, Barcelona, Spain
| | - Maria Chiara Spadaro
- Catalan Institute of Nanoscience and Nanotechnology (ICN2), CSIC and BIST, Campus UAB, Barcelona, Spain
| | - Clément Hébert
- Catalan Institute of Nanoscience and Nanotechnology (ICN2), CSIC and BIST, Campus UAB, Barcelona, Spain
| | - Sinead Savage
- Nanomedicine Lab, National Graphene Institute and Faculty of Biology, Medicine & Health, Manchester, UK
| | - Jordi Arbiol
- Catalan Institute of Nanoscience and Nanotechnology (ICN2), CSIC and BIST, Campus UAB, Barcelona, Spain
- ICREA, Barcelona, Spain
| | - Anton Guimerà-Brunet
- Institut de Microelectrònica de Barcelona, IMB-CNM (CSIC), Campus UAB, Bellaterra, Spain
| | - M Victoria Puig
- Catalan Institute of Nanoscience and Nanotechnology (ICN2), CSIC and BIST, Campus UAB, Barcelona, Spain
- Hospital del Mar Research Institute, Barcelona, Spain
| | - Blaise Yvert
- Univ. Grenoble Alpes, Inserm, U1216, Grenoble Institut Neurosciences, Grenoble, France
| | - Xavier Navarro
- Institute of Neurosciences, Department of Cell Biology, Physiology and Immunology, Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Universitat Autònoma de Barcelona, Barcelona, Spain
| | - Kostas Kostarelos
- Catalan Institute of Nanoscience and Nanotechnology (ICN2), CSIC and BIST, Campus UAB, Barcelona, Spain.
- Institute of Neurosciences, Department of Cell Biology, Physiology and Immunology, Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Universitat Autònoma de Barcelona, Barcelona, Spain.
- Nanomedicine Lab, National Graphene Institute and Faculty of Biology, Medicine & Health, Manchester, UK.
| | - Jose A Garrido
- Catalan Institute of Nanoscience and Nanotechnology (ICN2), CSIC and BIST, Campus UAB, Barcelona, Spain.
- ICREA, Barcelona, Spain.
| |
Collapse
|
2
|
Ogene L, Woods S, Hetmanski J, Lozano N, Karakasidi A, Caswell PT, Kostarelos K, Domingos MAN, Vranic S, Kimber SJ. Graphene oxide activates canonical TGFβ signalling in a human chondrocyte cell line via increased plasma membrane tension. Nanoscale 2024; 16:5653-5664. [PMID: 38414413 PMCID: PMC10939054 DOI: 10.1039/d3nr06033k] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/27/2023] [Accepted: 02/18/2024] [Indexed: 02/29/2024]
Abstract
Graphene Oxide (GO) has been shown to increase the expression of key cartilage genes and matrix components within 3D scaffolds. Understanding the mechanisms behind the chondroinductive ability of GO is critical for developing articular cartilage regeneration therapies but remains poorly understood. The objectives of this work were to elucidate the effects of GO on the key chondrogenic signalling pathway - TGFβ and identify the mechanism through which signal activation is achieved in human chondrocytes. Activation of canonical signalling was validated through GO-induced SMAD-2 phosphorylation and upregulation of known TGFβ response genes, while the use of a TGFβ signalling reporter assay allowed us to identify the onset of GO-induced signal activation which has not been previously reported. Importantly, we investigate the cell-material interactions and molecular mechanisms behind these effects, establishing a novel link between GO, the plasma membrane and intracellular signalling. By leveraging fluorescent lifetime imaging (FLIM) and a membrane tension probe, we reveal GO-mediated increases in plasma membrane tension, in real-time for the first time. Furthermore, we report the activation of mechanosensory pathways which are known to be regulated by changes in plasma membrane tension and reveal the activation of endogenous latent TGFβ in the presence of GO, providing a mechanism for signal activation. The data presented here are critical to understanding the chondroinductive properties of GO and are important for the implementation of GO in regenerative medicine.
Collapse
Affiliation(s)
- Leona Ogene
- Division of Cell Matrix Biology & Regenerative Medicine, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, M13 9PT, UK.
| | - Steven Woods
- Division of Cell Matrix Biology & Regenerative Medicine, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, M13 9PT, UK.
| | - Joseph Hetmanski
- Wellcome Trust Centre for Cell-Matrix Research, University of Manchester, Manchester Academic Health Science Centre, Manchester, M13 9PT, UK
| | - Neus Lozano
- Nanomedicine Lab, Catalan Institute of Nanoscience and Nanotechnology (ICN2), CSIC and BIST, Campus UAB Bellaterra, 08193 Barcelona, Spain
| | - Angeliki Karakasidi
- Nano-Cell Biology Lab, Division of Cell Matrix Biology & Regenerative Medicine, School of Biological Sciences, The University of Manchester, Manchester, M13 9PT, UK
| | - Patrick T Caswell
- Wellcome Trust Centre for Cell-Matrix Research, University of Manchester, Manchester Academic Health Science Centre, Manchester, M13 9PT, UK
| | - Kostas Kostarelos
- Nanomedicine Lab, Catalan Institute of Nanoscience and Nanotechnology (ICN2), CSIC and BIST, Campus UAB Bellaterra, 08193 Barcelona, Spain
- Institució Catalana de Recerca i Estudis Avançats (ICREA), Pg. Lluís Companys 23, Barcelona, Spain
- Centre for Nanotechnology in Medicine, Faculty of Biology Medicine & Health, The University of Manchester, Manchester, UK
| | - Marco A N Domingos
- Department of Solids and Structure, School of Engineering, Faculty of Science and Engineering, Henry Royce Institute, The University of Manchester, Manchester, UK
| | - Sandra Vranic
- Nano-Cell Biology Lab, Division of Cell Matrix Biology & Regenerative Medicine, School of Biological Sciences, The University of Manchester, Manchester, M13 9PT, UK
- Centre for Nanotechnology in Medicine, Faculty of Biology Medicine & Health, The University of Manchester, Manchester, UK
| | - Susan J Kimber
- Division of Cell Matrix Biology & Regenerative Medicine, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, M13 9PT, UK.
| |
Collapse
|
3
|
Lin H, Buerki-Thurnherr T, Kaur J, Wick P, Pelin M, Tubaro A, Carniel FC, Tretiach M, Flahaut E, Iglesias D, Vázquez E, Cellot G, Ballerini L, Castagnola V, Benfenati F, Armirotti A, Sallustrau A, Taran F, Keck M, Bussy C, Vranic S, Kostarelos K, Connolly M, Navas JM, Mouchet F, Gauthier L, Baker J, Suarez-Merino B, Kanerva T, Prato M, Fadeel B, Bianco A. Environmental and Health Impacts of Graphene and Other Two-Dimensional Materials: A Graphene Flagship Perspective. ACS Nano 2024; 18:6038-6094. [PMID: 38350010 PMCID: PMC10906101 DOI: 10.1021/acsnano.3c09699] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/06/2023] [Revised: 01/18/2024] [Accepted: 01/22/2024] [Indexed: 02/15/2024]
Abstract
Two-dimensional (2D) materials have attracted tremendous interest ever since the isolation of atomically thin sheets of graphene in 2004 due to the specific and versatile properties of these materials. However, the increasing production and use of 2D materials necessitate a thorough evaluation of the potential impact on human health and the environment. Furthermore, harmonized test protocols are needed with which to assess the safety of 2D materials. The Graphene Flagship project (2013-2023), funded by the European Commission, addressed the identification of the possible hazard of graphene-based materials as well as emerging 2D materials including transition metal dichalcogenides, hexagonal boron nitride, and others. Additionally, so-called green chemistry approaches were explored to achieve the goal of a safe and sustainable production and use of this fascinating family of nanomaterials. The present review provides a compact survey of the findings and the lessons learned in the Graphene Flagship.
Collapse
Affiliation(s)
- Hazel Lin
- CNRS,
UPR3572, Immunology, Immunopathology and Therapeutic Chemistry, ISIS, University of Strasbourg, 67000 Strasbourg, France
| | - Tina Buerki-Thurnherr
- Empa,
Swiss Federal Laboratories for Materials Science and Technology, Laboratory for Particles-Biology Interactions, 9014 St. Gallen, Switzerland
| | - Jasreen Kaur
- Nanosafety
& Nanomedicine Laboratory, Institute
of Environmental Medicine, Karolinska Institutet, 177 77 Stockholm, Sweden
| | - Peter Wick
- Empa,
Swiss Federal Laboratories for Materials Science and Technology, Laboratory for Particles-Biology Interactions, 9014 St. Gallen, Switzerland
| | - Marco Pelin
- Department
of Life Sciences, University of Trieste, 34127 Trieste, Italy
| | - Aurelia Tubaro
- Department
of Life Sciences, University of Trieste, 34127 Trieste, Italy
| | | | - Mauro Tretiach
- Department
of Life Sciences, University of Trieste, 34127 Trieste, Italy
| | - Emmanuel Flahaut
- CIRIMAT,
Université de Toulouse, CNRS, INPT,
UPS, 31062 Toulouse CEDEX 9, France
| | - Daniel Iglesias
- Facultad
de Ciencias y Tecnologías Químicas, Universidad de Castilla-La Mancha (UCLM), 13071 Ciudad Real, Spain
- Instituto
Regional de Investigación Científica Aplicada (IRICA), Universidad de Castilla-La Mancha (UCLM), 13071 Ciudad Real, Spain
| | - Ester Vázquez
- Facultad
de Ciencias y Tecnologías Químicas, Universidad de Castilla-La Mancha (UCLM), 13071 Ciudad Real, Spain
- Instituto
Regional de Investigación Científica Aplicada (IRICA), Universidad de Castilla-La Mancha (UCLM), 13071 Ciudad Real, Spain
| | - Giada Cellot
- International
School for Advanced Studies (SISSA), 34136 Trieste, Italy
| | - Laura Ballerini
- International
School for Advanced Studies (SISSA), 34136 Trieste, Italy
| | - Valentina Castagnola
- Center
for
Synaptic Neuroscience and Technology, Istituto
Italiano di Tecnologia, 16132 Genova, Italy
- IRCCS
Ospedale Policlinico San Martino, 16132 Genova, Italy
| | - Fabio Benfenati
- Center
for
Synaptic Neuroscience and Technology, Istituto
Italiano di Tecnologia, 16132 Genova, Italy
- IRCCS
Ospedale Policlinico San Martino, 16132 Genova, Italy
| | - Andrea Armirotti
- Analytical
Chemistry Facility, Istituto Italiano di
Tecnologia, 16163 Genoa, Italy
| | - Antoine Sallustrau
- Département
Médicaments et Technologies pour la Santé (DMTS), Université Paris-Saclay, CEA, INRAE, SIMoS, Gif-sur-Yvette 91191, France
| | - Frédéric Taran
- Département
Médicaments et Technologies pour la Santé (DMTS), Université Paris-Saclay, CEA, INRAE, SIMoS, Gif-sur-Yvette 91191, France
| | - Mathilde Keck
- Département
Médicaments et Technologies pour la Santé (DMTS), Université Paris-Saclay, CEA, INRAE, SIMoS, Gif-sur-Yvette 91191, France
| | - Cyrill Bussy
- Nanomedicine
Lab, Faculty of Biology, Medicine and Health, University of Manchester,
Manchester Academic Health Science Centre, National Graphene Institute, Manchester M13 9PT, United
Kingdom
| | - Sandra Vranic
- Nanomedicine
Lab, Faculty of Biology, Medicine and Health, University of Manchester,
Manchester Academic Health Science Centre, National Graphene Institute, Manchester M13 9PT, United
Kingdom
| | - Kostas Kostarelos
- Nanomedicine
Lab, Faculty of Biology, Medicine and Health, University of Manchester,
Manchester Academic Health Science Centre, National Graphene Institute, Manchester M13 9PT, United
Kingdom
| | - Mona Connolly
- Instituto Nacional de Investigación y Tecnología
Agraria
y Alimentaria (INIA), CSIC, Carretera de la Coruña Km 7,5, E-28040 Madrid, Spain
| | - José Maria Navas
- Instituto Nacional de Investigación y Tecnología
Agraria
y Alimentaria (INIA), CSIC, Carretera de la Coruña Km 7,5, E-28040 Madrid, Spain
| | - Florence Mouchet
- Laboratoire
Ecologie Fonctionnelle et Environnement, Université de Toulouse, CNRS, INPT, UPS, 31000 Toulouse, France
| | - Laury Gauthier
- Laboratoire
Ecologie Fonctionnelle et Environnement, Université de Toulouse, CNRS, INPT, UPS, 31000 Toulouse, France
| | - James Baker
- TEMAS Solutions GmbH, 5212 Hausen, Switzerland
| | | | - Tomi Kanerva
- Finnish Institute of Occupational Health, 00250 Helsinki, Finland
| | - Maurizio Prato
- Center
for Cooperative Research in Biomaterials (CIC biomaGUNE), Basque Research and Technology Alliance (BRTA), 20014 Donostia-San
Sebastián, Spain
- Ikerbasque, Basque Foundation for Science, 48013 Bilbao, Spain
- Department
of Chemical and Pharmaceutical Sciences, University of Trieste, 34127 Trieste, Italy
| | - Bengt Fadeel
- Nanosafety
& Nanomedicine Laboratory, Institute
of Environmental Medicine, Karolinska Institutet, 177 77 Stockholm, Sweden
| | - Alberto Bianco
- CNRS,
UPR3572, Immunology, Immunopathology and Therapeutic Chemistry, ISIS, University of Strasbourg, 67000 Strasbourg, France
| |
Collapse
|
4
|
Andrews JPM, Joshi SS, Tzolos E, Syed MB, Cuthbert H, Crica LE, Lozano N, Okwelogu E, Raftis JB, Bruce L, Poland CA, Duffin R, Fokkens PHB, Boere AJF, Leseman DLAC, Megson IL, Whitfield PD, Ziegler K, Tammireddy S, Hadjidemetriou M, Bussy C, Cassee FR, Newby DE, Kostarelos K, Miller MR. First-in-human controlled inhalation of thin graphene oxide nanosheets to study acute cardiorespiratory responses. Nat Nanotechnol 2024:10.1038/s41565-023-01572-3. [PMID: 38366225 DOI: 10.1038/s41565-023-01572-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/11/2023] [Accepted: 11/09/2023] [Indexed: 02/18/2024]
Abstract
Graphene oxide nanomaterials are being developed for wide-ranging applications but are associated with potential safety concerns for human health. We conducted a double-blind randomized controlled study to determine how the inhalation of graphene oxide nanosheets affects acute pulmonary and cardiovascular function. Small and ultrasmall graphene oxide nanosheets at a concentration of 200 μg m-3 or filtered air were inhaled for 2 h by 14 young healthy volunteers in repeated visits. Overall, graphene oxide nanosheet exposure was well tolerated with no adverse effects. Heart rate, blood pressure, lung function and inflammatory markers were unaffected irrespective of graphene oxide particle size. Highly enriched blood proteomics analysis revealed very few differential plasma proteins and thrombus formation was mildly increased in an ex vivo model of arterial injury. Overall, acute inhalation of highly purified and thin nanometre-sized graphene oxide nanosheets was not associated with overt detrimental effects in healthy humans. These findings demonstrate the feasibility of carefully controlled human exposures at a clinical setting for risk assessment of graphene oxide, and lay the foundations for investigating the effects of other two-dimensional nanomaterials in humans. Clinicaltrials.gov ref: NCT03659864.
Collapse
Affiliation(s)
- Jack P M Andrews
- BHF Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK
- The Royal Infirmary of Edinburgh, Edinburgh, UK
| | - Shruti S Joshi
- BHF Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK
| | - Evangelos Tzolos
- BHF Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK
| | - Maaz B Syed
- BHF Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK
| | | | - Livia E Crica
- Nanomedicine Lab, Faculty of Biology Medicine and Health, The University of Manchester, Manchester, UK
- National Graphene Institute, The University of Manchester, Manchester, UK
| | - Neus Lozano
- Catalan Institute of Nanoscience and Nanotechnology (ICN2), CSIC and BIST, Campus UAB, Barcelona, Spain
| | - Emmanuel Okwelogu
- Nanomedicine Lab, Faculty of Biology Medicine and Health, The University of Manchester, Manchester, UK
| | - Jennifer B Raftis
- BHF Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK
| | - Lorraine Bruce
- BHF Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK
| | - Craig A Poland
- Centre for Inflammation Research, University of Edinburgh, Edinburgh, UK
| | - Rodger Duffin
- Centre for Inflammation Research, University of Edinburgh, Edinburgh, UK
| | - Paul H B Fokkens
- National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands
| | - A John F Boere
- National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands
| | - Daan L A C Leseman
- National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands
| | - Ian L Megson
- Division of Biomedical Sciences, University of the Highlands and Islands, Inverness, UK
| | - Phil D Whitfield
- Division of Biomedical Sciences, University of the Highlands and Islands, Inverness, UK
| | - Kerstin Ziegler
- Division of Biomedical Sciences, University of the Highlands and Islands, Inverness, UK
| | - Seshu Tammireddy
- Division of Biomedical Sciences, University of the Highlands and Islands, Inverness, UK
| | - Marilena Hadjidemetriou
- Nanomedicine Lab, Faculty of Biology Medicine and Health, The University of Manchester, Manchester, UK
| | - Cyrill Bussy
- Nanomedicine Lab, Faculty of Biology Medicine and Health, The University of Manchester, Manchester, UK
- National Graphene Institute, The University of Manchester, Manchester, UK
- Lydia Becker Institute of Immunology and Inflammation, The University of Manchester, Manchester, UK
- Thomas Ashton Institute for Risk and Regulatory Research, The University of Manchester, Manchester, UK
| | - Flemming R Cassee
- National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands
- Institute for Risk Assessment Sciences, Utrecht University, Utrecht, The Netherlands
| | - David E Newby
- BHF Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK
| | - Kostas Kostarelos
- Nanomedicine Lab, Faculty of Biology Medicine and Health, The University of Manchester, Manchester, UK.
- National Graphene Institute, The University of Manchester, Manchester, UK.
- Catalan Institute of Nanoscience and Nanotechnology (ICN2), CSIC and BIST, Campus UAB, Barcelona, Spain.
- Institució Catalana de Recerca i Estudis Avançats (ICREA), Pg. Lluís Companys 23, Barcelona, Spain.
| | - Mark R Miller
- BHF Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK.
| |
Collapse
|
5
|
Visani de Luna LA, Loret T, He Y, Legnani M, Lin H, Galibert AM, Fordham A, Holme S, Del Rio Castillo AE, Bonaccorso F, Bianco A, Flahaut E, Kostarelos K, Bussy C. Pulmonary Toxicity of Boron Nitride Nanomaterials Is Aspect Ratio Dependent. ACS Nano 2023; 17:24919-24935. [PMID: 38051272 PMCID: PMC10753895 DOI: 10.1021/acsnano.3c06599] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/18/2023] [Revised: 11/26/2023] [Accepted: 12/01/2023] [Indexed: 12/07/2023]
Abstract
Boron nitride (BN) nanomaterials have drawn a lot of interest in the material science community. However, extensive research is still needed to thoroughly analyze their safety profiles. Herein, we investigated the pulmonary impact and clearance of two-dimensional hexagonal boron nitride (h-BN) nanosheets and boron nitride nanotubes (BNNTs) in mice. Animals were exposed by single oropharyngeal aspiration to h-BN or BNNTs. On days 1, 7, and 28, bronchoalveolar lavage (BAL) fluids and lungs were collected. On one hand, adverse effects on lungs were evaluated using various approaches (e.g., immune response, histopathology, tissue remodeling, and genotoxicity). On the other hand, material deposition and clearance from the lungs were assessed. Two-dimensional h-BN did not cause any significant immune response or lung damage, although the presence of materials was confirmed by Raman spectroscopy. In addition, the low aspect ratio h-BN nanosheets were internalized rapidly by phagocytic cells present in alveoli, resulting in efficient clearance from the lungs. In contrast, high aspect ratio BNNTs caused a strong and long-lasting inflammatory response, characterized by sustained inflammation up to 28 days after exposure and the activation of both innate and adaptive immunity. Moreover, the presence of granulomatous structures and an indication of ongoing fibrosis as well as DNA damage in the lung parenchyma were evidenced with these materials. Concurrently, BNNTs were identified in lung sections for up to 28 days, suggesting long-term biopersistence, as previously demonstrated for other high aspect ratio nanomaterials with poor lung clearance such as multiwalled carbon nanotubes (MWCNTs). Overall, we reveal the safer toxicological profile of BN-based two-dimensional nanosheets in comparison to their nanotube counterparts. We also report strong similarities between BNNTs and MWCNTs in lung response, emphasizing their high aspect ratio as a major driver of their toxicity.
Collapse
Affiliation(s)
- Luis Augusto Visani de Luna
- Nanomedicine
Lab, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester Academic Health Science
Centre, Manchester M13 9PT, U.K.
- National
Graphene Institute, The University of Manchester, Manchester, M13 9PL, U.K.
- Lydia
Becker Institute of Immunology and Inflammation, Faculty of Biology,
Medicine and Health, The University of Manchester,
Manchester Academic Health Science Centre, Manchester M13 9PT, U.K.
| | - Thomas Loret
- Nanomedicine
Lab, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester Academic Health Science
Centre, Manchester M13 9PT, U.K.
- National
Graphene Institute, The University of Manchester, Manchester, M13 9PL, U.K.
- Lydia
Becker Institute of Immunology and Inflammation, Faculty of Biology,
Medicine and Health, The University of Manchester,
Manchester Academic Health Science Centre, Manchester M13 9PT, U.K.
| | - Yilin He
- CNRS,
Immunology, Immunopathology and Therapeutic Chemistry, UPR 3572, University
of Strasbourg, ISIS, 67000 Strasbourg, France
| | - Morgan Legnani
- CIRIMAT,
Université Toulouse 3 Paul Sabatier, Toulouse INP, CNRS, Université
de Toulouse, 118 Route de Narbonne, 31062 Toulouse cedex 9, France
| | - Hazel Lin
- CNRS,
Immunology, Immunopathology and Therapeutic Chemistry, UPR 3572, University
of Strasbourg, ISIS, 67000 Strasbourg, France
| | - Anne Marie Galibert
- CIRIMAT,
Université Toulouse 3 Paul Sabatier, Toulouse INP, CNRS, Université
de Toulouse, 118 Route de Narbonne, 31062 Toulouse cedex 9, France
| | - Alexander Fordham
- Nanomedicine
Lab, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester Academic Health Science
Centre, Manchester M13 9PT, U.K.
- National
Graphene Institute, The University of Manchester, Manchester, M13 9PL, U.K.
- Lydia
Becker Institute of Immunology and Inflammation, Faculty of Biology,
Medicine and Health, The University of Manchester,
Manchester Academic Health Science Centre, Manchester M13 9PT, U.K.
| | - Sonja Holme
- Nanomedicine
Lab, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester Academic Health Science
Centre, Manchester M13 9PT, U.K.
- National
Graphene Institute, The University of Manchester, Manchester, M13 9PL, U.K.
- Lydia
Becker Institute of Immunology and Inflammation, Faculty of Biology,
Medicine and Health, The University of Manchester,
Manchester Academic Health Science Centre, Manchester M13 9PT, U.K.
| | | | - Francesco Bonaccorso
- BeDimensional
S.p.A., Lungo Torrente
Secca 30r, 16163 Genoa, Italy
- Istituto
Italiano di Tecnologia, Graphene Laboratories, Via Morego 30, 16163 Genoa, Italy
| | - Alberto Bianco
- CNRS,
Immunology, Immunopathology and Therapeutic Chemistry, UPR 3572, University
of Strasbourg, ISIS, 67000 Strasbourg, France
| | - Emmanuel Flahaut
- CIRIMAT,
Université Toulouse 3 Paul Sabatier, Toulouse INP, CNRS, Université
de Toulouse, 118 Route de Narbonne, 31062 Toulouse cedex 9, France
| | - Kostas Kostarelos
- Nanomedicine
Lab, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester Academic Health Science
Centre, Manchester M13 9PT, U.K.
- National
Graphene Institute, The University of Manchester, Manchester, M13 9PL, U.K.
- Catalan
Institute of Nanoscience and Nanotechnology (ICN2), CSIC and BIST,, Campus UAB, Bellaterra, 08193 Barcelona, Spain
| | - Cyrill Bussy
- Nanomedicine
Lab, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester Academic Health Science
Centre, Manchester M13 9PT, U.K.
- National
Graphene Institute, The University of Manchester, Manchester, M13 9PL, U.K.
- Lydia
Becker Institute of Immunology and Inflammation, Faculty of Biology,
Medicine and Health, The University of Manchester,
Manchester Academic Health Science Centre, Manchester M13 9PT, U.K.
| |
Collapse
|
6
|
Tortella L, Santini I, Lozano N, Kostarelos K, Cellot G, Ballerini L. Graphene Oxide Nanosheets Hamper Glutamate Mediated Excitotoxicity and Protect Neuronal Survival In An In vitro Stroke Model. Chemistry 2023; 29:e202301762. [PMID: 37706581 DOI: 10.1002/chem.202301762] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/05/2023] [Revised: 09/06/2023] [Accepted: 09/13/2023] [Indexed: 09/15/2023]
Abstract
Small graphene oxide (s-GO) nanosheets reversibly downregulate central nervous system (CNS) excitatory synapses, with potential developments as future therapeutic tools to treat neuro-disorders characterized by altered glutamatergic transmission. Excitotoxicity, namely cell death triggered by exceeding ambient glutamate fueling over-activation of excitatory synapses, is a pathogenic mechanism shared by several neural diseases, from ischemic stroke to neurodegenerative disorders. In this work, CNS cultures were exposed to oxygen-glucose deprivation (OGD) to mimic ischemic stroke in vitro, and it is show that the delivery of s-GO following OGD, during the endogenous build-up of secondary damage and excitotoxicity, improved neuronal survival. In a different paradigm, excitotoxicity cell damage was reproduced through exogenous glutamate application, and s-GO co-treatment protected neuronal integrity, potentially by directly downregulating the synaptic over-activation brought about by exogenous glutamate. This proof-of-concept study suggests that s-GO may find novel applications in therapeutic developments for treating excitotoxicity-driven neural cell death.
Collapse
Affiliation(s)
- Lorenza Tortella
- Neuroscience Area, International School for Advanced Studies (SISSA/ISAS), Via Bonomea 265, 34136, Trieste, Italy
| | - Irene Santini
- Neuroscience Area, International School for Advanced Studies (SISSA/ISAS), Via Bonomea 265, 34136, Trieste, Italy
| | - Neus Lozano
- Catalan Institute of Nanoscience and Nanotechnology (ICN2), CSIC and BIST, Campus UAB, Bellaterra, 08193, Barcelona, Spain
| | - Kostas Kostarelos
- Catalan Institute of Nanoscience and Nanotechnology (ICN2), CSIC and BIST, Campus UAB, Bellaterra, 08193, Barcelona, Spain
- Nanomedicine Lab, and Faculty of Biology, Medicine & Health, The National Graphene Institute, University of Manchester, Manchester, M13 9PL, United Kingdom
| | - Giada Cellot
- Neuroscience Area, International School for Advanced Studies (SISSA/ISAS), Via Bonomea 265, 34136, Trieste, Italy
| | - Laura Ballerini
- Neuroscience Area, International School for Advanced Studies (SISSA/ISAS), Via Bonomea 265, 34136, Trieste, Italy
| |
Collapse
|
7
|
Pati E, Franceschi Biagioni A, Casani R, Lozano N, Kostarelos K, Cellot G, Ballerini L. Delivery of graphene oxide nanosheets modulates glutamate release and normalizes amygdala synaptic plasticity to improve anxiety-related behavior. Nanoscale 2023; 15:18581-18591. [PMID: 37955642 DOI: 10.1039/d3nr04490d] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/14/2023]
Abstract
Graphene oxide nanosheets (GO) were reported to alter neurobiological processes involving cell membrane dynamics. GO ability to reversibly downregulate specifically glutamatergic synapses underpins their potential in future neurotherapeutic developments. Aberrant glutamate plasticity contributes to stress-related psychopathology and drugs which target dysregulated glutamate represent promising treatments. We find that in a rat model of post-traumatic stress disorder (PTSD), a single injection of GO to the lateral amygdala following the stressful event induced PTSD-related behavior remission and reduced dendritic spine densities. We explored from a mechanistic perspective how GO could impair glutamate synaptic plasticity. By simultaneous patch clamp pair recordings of unitary synaptic currents, live-imaging of presynaptic vesicle release and confocal microscopy, we report that GO nanosheets altered the probability of release enhancing the extinction of synaptic plasticity in the amygdala. These findings show that the modulation of presynaptic glutamate release might represent an unexplored target for (nano)pharmacological interventions of stress-related disorders.
Collapse
Affiliation(s)
- Elisa Pati
- Neuroscience Area, International School for Advanced Studies (SISSA/ISAS), 34136 Trieste, Italy.
| | | | - Raffaele Casani
- Neuroscience Area, International School for Advanced Studies (SISSA/ISAS), 34136 Trieste, Italy.
| | - Neus Lozano
- Nanomedicine Lab Catalan Institute of Nanoscience and Nanotechnology (ICN2), CSIC and BIST, Campus UAB, Bellaterra, 08193 Barcelona, Spain
| | - Kostas Kostarelos
- Nanomedicine Lab Catalan Institute of Nanoscience and Nanotechnology (ICN2), CSIC and BIST, Campus UAB, Bellaterra, 08193 Barcelona, Spain
- Nanomedicine Lab, and Faculty of Biology, Medicine & Health, The National Graphene Institute, University of Manchester, Manchester, M13 9PL, UK
| | - Giada Cellot
- Neuroscience Area, International School for Advanced Studies (SISSA/ISAS), 34136 Trieste, Italy.
| | - Laura Ballerini
- Neuroscience Area, International School for Advanced Studies (SISSA/ISAS), 34136 Trieste, Italy.
| |
Collapse
|
8
|
Loret T, de Luna LAV, Lucherelli MA, Fordham A, Lozano N, Bianco A, Kostarelos K, Bussy C. Lung Persistence, Biodegradation, and Elimination of Graphene-Based Materials are Predominantly Size-Dependent and Mediated by Alveolar Phagocytes. Small 2023; 19:e2301201. [PMID: 37264768 DOI: 10.1002/smll.202301201] [Citation(s) in RCA: 6] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/10/2023] [Revised: 04/03/2023] [Indexed: 06/03/2023]
Abstract
Graphene-based materials (GBMs) have promising applications in various sectors, including pulmonary nanomedicine. Nevertheless, the influence of GBM physicochemical characteristics on their fate and impact in lung has not been thoroughly addressed. To fill this gap, the biological response, distribution, and bio-persistence of four different GBMs in mouse lungs up to 28 days after single oropharyngeal aspiration are investigated. None of the GBMs, varying in size (large versus small) and carbon to oxygen ratio as well as thickness (few-layers graphene (FLG) versus thin graphene oxide (GO)), induce a strong pulmonary immune response. However, recruited neutrophils internalize nanosheets better and degrade GBMs faster than macrophages, revealing their crucial role in the elimination of small GBMs. In contrast, large GO sheets induce more damages due to a hindered degradation and long-term persistence in macrophages. Overall, small dimensions appear to be a leading feature in the design of safe GBM pulmonary nanovectors due to an enhanced degradation in phagocytes and a faster clearance from the lungs for small GBMs. Thickness also plays an important role, since decreased material loading in alveolar phagocytes and faster elimination are found for FLGs compared to thinner GOs. These results are important for designing safer-by-design GBMs for biomedical application.
Collapse
Affiliation(s)
- Thomas Loret
- Nanomedicine Lab 2.0, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Manchester, M13 9PT, UK
- National Graphene Institute, The University of Manchester, Manchester, M13 9PL, UK
- Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Manchester, M13 9PT, UK
| | - Luis Augusto Visani de Luna
- Nanomedicine Lab 2.0, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Manchester, M13 9PT, UK
- National Graphene Institute, The University of Manchester, Manchester, M13 9PL, UK
- Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Manchester, M13 9PT, UK
| | - Matteo Andrea Lucherelli
- CNRS, Immunology, Immunopathology and Therapeutic Chemistry, UPR 3572, University of Strasbourg, ISIS, Strasbourg, 67000, France
| | - Alexander Fordham
- Nanomedicine Lab 2.0, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Manchester, M13 9PT, UK
- National Graphene Institute, The University of Manchester, Manchester, M13 9PL, UK
- Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Manchester, M13 9PT, UK
| | - Neus Lozano
- Catalan Institute of Nanoscience and Nanotechnology (ICN2), CSIC and BIST, Campus UAB, Bellaterra, Barcelona, 08193, Spain
| | - Alberto Bianco
- CNRS, Immunology, Immunopathology and Therapeutic Chemistry, UPR 3572, University of Strasbourg, ISIS, Strasbourg, 67000, France
| | - Kostas Kostarelos
- Nanomedicine Lab 2.0, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Manchester, M13 9PT, UK
- National Graphene Institute, The University of Manchester, Manchester, M13 9PL, UK
- Catalan Institute of Nanoscience and Nanotechnology (ICN2), CSIC and BIST, Campus UAB, Bellaterra, Barcelona, 08193, Spain
| | - Cyrill Bussy
- Nanomedicine Lab 2.0, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Manchester, M13 9PT, UK
- National Graphene Institute, The University of Manchester, Manchester, M13 9PL, UK
- Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Manchester, M13 9PT, UK
| |
Collapse
|
9
|
Chen Y, Taufiq T, Zeng N, Lozano N, Karakasidi A, Church H, Jovanovic A, Jones SA, Panigrahi A, Larrosa I, Kostarelos K, Casiraghi C, Vranic S. Defect-free graphene enhances enzyme delivery to fibroblasts derived from patients with lysosomal storage disorders. Nanoscale 2023. [PMID: 37165691 DOI: 10.1039/d2nr04971f] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/12/2023]
Abstract
Enzyme replacement therapy shows remarkable clinical improvement in treating lysosomal storage disorders. However, this therapeutic approach is hampered by limitations in the delivery of the enzyme to cells and tissues. Therefore, there is an urgent, unmet clinical need to develop new strategies to enhance the enzyme delivery to diseased cells. Graphene-based materials, due to their dimensionality and favourable pattern of interaction with cells, represent a promising platform for the loading and delivery of therapeutic cargo. Herein, the potential use of graphene-based materials, including defect-free graphene with positive or negative surface charge and graphene oxide with different lateral dimensions, was investigated for the delivery of lysosomal enzymes in fibroblasts derived from patients with Mucopolysaccharidosis VI and Pompe disease. We report excellent biocompatibility of all graphene-based materials up to a concentration of 100 μg mL-1 in the cell lines studied. In addition, a noticeable difference in the uptake profile of the materials was observed. Neither type of graphene oxide was taken up by the cells to a significant extent. In contrast, the two types of graphene were efficiently taken up, localizing in the lysosomes. Furthermore, we demonstrate that cationic graphene flakes can be used as carriers for arylsulfatase B enzyme, for the delivery of the lacking enzyme to the lysosomes of Mucopolysaccharidosis VI fibroblasts. Arylsulfatase B complexed with cationic graphene flakes not only retained the enzymatic activity, but also exerted biological effects almost twice as high as arylsulfatase B alone in the clearance of the substrate in Mucopolysaccharidosis VI fibroblasts. This study lays the groundwork for the potential use of graphene-based materials as carriers for enzyme replacement therapy in lysosomal storage disorders.
Collapse
Affiliation(s)
- Yingxian Chen
- Nanomedicine Lab, Faculty of Biology, Medicine and Health, The University of Manchester, AV Hill Building, Manchester M13 9PT, UK.
- National Graphene Institute, The University of Manchester, Booth Street East, Manchester M13 9PL, UK
| | - Tooba Taufiq
- Nanomedicine Lab, Faculty of Biology, Medicine and Health, The University of Manchester, AV Hill Building, Manchester M13 9PT, UK.
- National Graphene Institute, The University of Manchester, Booth Street East, Manchester M13 9PL, UK
| | - Niting Zeng
- Department of Chemistry, University of Manchester, Oxford Road, Manchester, UK
| | - Neus Lozano
- Catalan Institute of Nanoscience and Nanotechnology (ICN2), CSIC and BIST, Campus UAB, Bellaterra, 08193 Barcelona, Spain
| | - Angeliki Karakasidi
- Nanomedicine Lab, Faculty of Biology, Medicine and Health, The University of Manchester, AV Hill Building, Manchester M13 9PT, UK.
- National Graphene Institute, The University of Manchester, Booth Street East, Manchester M13 9PL, UK
| | - Heather Church
- Manchester Centre for Genomic Medicine, Manchester University NHS Foundation Trust, Oxford Road, Manchester, UK
| | - Ana Jovanovic
- Adult Inherited Metabolic Department, Salford Royal NHS Foundation Trust, Manchester M6 8HD, UK
| | - Simon A Jones
- Manchester Centre for Genomic Medicine, Manchester University NHS Foundation Trust, Oxford Road, Manchester, UK
| | - Adyasha Panigrahi
- Department of Chemistry, University of Manchester, Oxford Road, Manchester, UK
| | - Igor Larrosa
- Department of Chemistry, University of Manchester, Oxford Road, Manchester, UK
| | - Kostas Kostarelos
- Nanomedicine Lab, Faculty of Biology, Medicine and Health, The University of Manchester, AV Hill Building, Manchester M13 9PT, UK.
- National Graphene Institute, The University of Manchester, Booth Street East, Manchester M13 9PL, UK
- Catalan Institute of Nanoscience and Nanotechnology (ICN2), CSIC and BIST, Campus UAB, Bellaterra, 08193 Barcelona, Spain
| | - Cinzia Casiraghi
- Department of Chemistry, University of Manchester, Oxford Road, Manchester, UK
| | - Sandra Vranic
- Nanomedicine Lab, Faculty of Biology, Medicine and Health, The University of Manchester, AV Hill Building, Manchester M13 9PT, UK.
- National Graphene Institute, The University of Manchester, Booth Street East, Manchester M13 9PL, UK
| |
Collapse
|
10
|
Cazier H, Malgorn C, Georgin D, Fresneau N, Beau F, Kostarelos K, Bussy C, Campidelli S, Pinault M, Mayne-L'Hermite M, Taran F, Junot C, Fenaille F, Sallustrau A, Colsch B. Correlative radioimaging and mass spectrometry imaging: a powerful combination to study 14C-graphene oxide in vivo biodistribution. Nanoscale 2023; 15:5510-5518. [PMID: 36853236 DOI: 10.1039/d2nr06753f] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/18/2023]
Abstract
Research on graphene based nanomaterials has flourished in the last decade due their unique properties and emerging socio-economic impact. In the context of their potential exploitation for biomedical applications, there is a growing need for the development of more efficient imaging techniques to track the fate of these materials. Herein we propose the first correlative imaging approach based on the combination of radioimaging and mass spectrometry imaging for the detection of Graphene Oxide (GO) labelled with carbon-14 in mice. In this study, 14C-graphene oxide nanoribbons were produced from the oxidative opening of 14C-carbon nanotubes, and were then intensively sonicated to provide nano-size 14C-GO flakes. After Intravenous administration in mice, 14C-GO distribution was quantified by radioimaging performed on tissue slices. On the same slices, MS-imaging provided a highly resolved distribution map of the nanomaterial based on the detection of specific radical anionic carbon clusters ranging from C2˙- to C9˙- with a base peak at m/z 72 (12C) and 74 (14C) under negative laser desorption ionization mass spectrometry (LDI-MS) conditions. This proof of concept approach synergizes the strength of each technique and could be advantageous in the pre-clinical development of future Graphene-based biomedical applications.
Collapse
Affiliation(s)
- Hélène Cazier
- Université Paris Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé (DMTS), SPI, 91191 Gif-sur-Yvette, France
| | - Carole Malgorn
- Université Paris Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé (DMTS), SiMos, 91191 Gif-sur-Yvette, France
| | - Dominique Georgin
- Université Paris Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé (DMTS), SCBM, 91191 Gif-sur-Yvette, France.
| | - Nathalie Fresneau
- Université Paris Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé (DMTS), SCBM, 91191 Gif-sur-Yvette, France.
- Université Paris Saclay, CEA, CNRS, NIMBE, LICSEN, 91191 Gif-sur-Yvette, France
| | - Fabrice Beau
- Université Paris Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé (DMTS), SiMos, 91191 Gif-sur-Yvette, France
| | - Kostas Kostarelos
- Nanomedicine Lab, Faculty of Biology, Medicine and Health, AV Hill Building, University of Manchester, Manchester M13 9PL, UK
- National Graphene Institute, University of Manchester, Manchester M13 9PL, UK
- Catalan Institute of Nanoscience and Nanotechnology (ICN2), UAB Campus Bellaterra, Barcelona 08193, Spain
| | - Cyrill Bussy
- Nanomedicine Lab, Faculty of Biology, Medicine and Health, AV Hill Building, University of Manchester, Manchester M13 9PL, UK
- National Graphene Institute, University of Manchester, Manchester M13 9PL, UK
| | - Stéphane Campidelli
- Université Paris Saclay, CEA, CNRS, NIMBE, LICSEN, 91191 Gif-sur-Yvette, France
| | - Mathieu Pinault
- Université Paris-Saclay, CEA, CNRS, NIMBE, LEDNA, 91191 Gif-sur-Yvette, France
| | | | - Frédéric Taran
- Université Paris Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé (DMTS), SCBM, 91191 Gif-sur-Yvette, France.
| | - Christophe Junot
- Université Paris Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé (DMTS), SPI, 91191 Gif-sur-Yvette, France
| | - François Fenaille
- Université Paris Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé (DMTS), SPI, 91191 Gif-sur-Yvette, France
| | - Antoine Sallustrau
- Université Paris Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé (DMTS), SCBM, 91191 Gif-sur-Yvette, France.
| | - Benoit Colsch
- Université Paris Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé (DMTS), SPI, 91191 Gif-sur-Yvette, France
| |
Collapse
|
11
|
Di Mauro G, Amoriello R, Lozano N, Carnasciali A, Guasti D, Becucci M, Cellot G, Kostarelos K, Ballerini C, Ballerini L. Graphene Oxide Nanosheets Reduce Astrocyte Reactivity to Inflammation and Ameliorate Experimental Autoimmune Encephalomyelitis. ACS Nano 2023; 17:1965-1978. [PMID: 36692902 PMCID: PMC9933621 DOI: 10.1021/acsnano.2c06609] [Citation(s) in RCA: 6] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 07/05/2022] [Accepted: 01/10/2023] [Indexed: 06/17/2023]
Abstract
In neuroinflammation, astrocytes play multifaceted roles that regulate the neuronal environment. Astrocytes sense and respond to pro-inflammatory cytokines (CKs) and, by a repertoire of intracellular Ca2+ signaling, contribute to disease progression. Therapeutic approaches wish to reduce the overactivation in Ca2+ signaling in inflammatory-reactive astrocytes to restore dysregulated cellular changes. Cell-targeting therapeutics might take advantage by the use of nanomaterial-multifunctional platforms such as graphene oxide (GO). GO biomedical applications in the nervous system involve therapeutic delivery and sensing, and GO flakes were shown to enable interfacing of neuronal and glial membrane dynamics. We exploit organotypic spinal cord cultures and optical imaging to explore Ca2+ changes in astrocytes, and we report, when spinal tissue is exposed to CKs, neuroinflammatory-associated modulation of resident glia. We show the efficacy of GO to revert these dynamic changes in astrocytic reactivity to CKs, and we translate this potential in an animal model of immune-mediated neuroinflammatory disease.
Collapse
Affiliation(s)
- Giuseppe Di Mauro
- International
School for Advanced Studies (SISSA/ISAS), 34136Trieste, Italy
| | - Roberta Amoriello
- International
School for Advanced Studies (SISSA/ISAS), 34136Trieste, Italy
- Dipartimento
di Medicina Sperimentale e Clinica, University
of Florence, 50139Florence, Italy
| | - Neus Lozano
- Catalan
Institute of Nanoscience and Nanotechnology (ICN2), 08193Barcelona, Spain
| | - Alberto Carnasciali
- Dipartimento
di Medicina Sperimentale e Clinica, University
of Florence, 50139Florence, Italy
| | - Daniele Guasti
- Dipartimento
di Medicina Sperimentale e Clinica, University
of Florence, 50139Florence, Italy
| | - Maurizio Becucci
- Dipartimento
di Chimica “Ugo Schiff”, DICUS, University of Florence, 50139Florence, Italy
| | - Giada Cellot
- International
School for Advanced Studies (SISSA/ISAS), 34136Trieste, Italy
| | - Kostas Kostarelos
- Catalan
Institute of Nanoscience and Nanotechnology (ICN2), 08193Barcelona, Spain
- Nanomedicine
Lab, and Faculty of Biology, Medicine & Health, The National Graphene
Institute, University of Manchester, ManchesterM13 9PL, United Kingdom
| | - Clara Ballerini
- Dipartimento
di Medicina Sperimentale e Clinica, University
of Florence, 50139Florence, Italy
| | - Laura Ballerini
- International
School for Advanced Studies (SISSA/ISAS), 34136Trieste, Italy
| |
Collapse
|
12
|
Peng G, Sinkko HM, Alenius H, Lozano N, Kostarelos K, Bräutigam L, Fadeel B. Graphene oxide elicits microbiome-dependent type 2 immune responses via the aryl hydrocarbon receptor. Nat Nanotechnol 2023; 18:42-48. [PMID: 36509925 PMCID: PMC9879769 DOI: 10.1038/s41565-022-01260-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 12/17/2020] [Accepted: 10/12/2022] [Indexed: 06/17/2023]
Abstract
The gut microbiome produces metabolites that interact with the aryl hydrocarbon receptor (AhR), a key regulator of immune homoeostasis in the gut1,2. Here we show that oral exposure to graphene oxide (GO) modulates the composition of the gut microbiome in adult zebrafish, with significant differences in wild-type versus ahr2-deficient animals. Furthermore, GO was found to elicit AhR-dependent induction of cyp1a and homing of lck+ cells to the gut in germ-free zebrafish larvae when combined with the short-chain fatty acid butyrate. To obtain further insights into the immune responses to GO, we used single-cell RNA sequencing to profile cells from whole germ-free embryos as well as cells enriched for lck. These studies provided evidence for the existence of innate lymphoid cell (ILC)-like cells3 in germ-free zebrafish. Moreover, GO endowed with a 'corona' of microbial butyrate triggered the induction of ILC2-like cells with attributes of regulatory cells. Taken together, this study shows that a nanomaterial can influence the crosstalk between the microbiome and immune system in an AhR-dependent manner.
Collapse
Affiliation(s)
- Guotao Peng
- Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
| | - Hanna M Sinkko
- Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
- Human Microbiome Research Program (HUMI), University of Helsinki, Helsinki, Finland
| | - Harri Alenius
- Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
- Human Microbiome Research Program (HUMI), University of Helsinki, Helsinki, Finland
| | - Neus Lozano
- Catalan Institute of Nanoscience and Nanotechnology (ICN2), Bellaterra, Spain
| | - Kostas Kostarelos
- Catalan Institute of Nanoscience and Nanotechnology (ICN2), Bellaterra, Spain
- National Graphene Institute, and Faculty of Biology, Medicine & Health, University of Manchester, Manchester, UK
| | - Lars Bräutigam
- Comparative Medicine, Karolinska Institutet, Stockholm, Sweden
| | - Bengt Fadeel
- Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
| |
Collapse
|
13
|
Sharp PS, Stylianou M, Arellano LM, Neves JC, Gravagnuolo AM, Dodd A, Barr K, Lozano N, Kisby T, Kostarelos K. Graphene Oxide Nanoscale Platform Enhances the Anti-Cancer Properties of Bortezomib in Glioblastoma Models. Adv Healthc Mater 2023; 12:e2201968. [PMID: 36300643 DOI: 10.1002/adhm.202201968] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/04/2022] [Revised: 10/03/2022] [Indexed: 01/26/2023]
Abstract
Graphene-based 2D nanomaterials possess unique physicochemical characteristics which can be utilized in various biomedical applications, including the transport and presentation of chemotherapeutic agents. In glioblastoma multiforme (GBM), intratumorally administered thin graphene oxide (GO) nanosheets demonstrate a widespread distribution throughout the tumor volume without impact on tumor growth, nor spread into normal brain tissue. Such intratumoral localization and distribution can offer multiple opportunities for treatment and modulation of the GBM microenvironment. Here, the kinetics of GO nanosheet distribution in orthotopic GBM mouse models is described and a novel nano-chemotherapeutic approach utilizing thin GO sheets as platforms to non-covalently complex a proteasome inhibitor, bortezomib (BTZ), is rationally designed. Through the characterization of the GO:BTZ complexes, a high loading capacity of the small molecule on the GO surface with sustained BTZ biological activity in vitro is demonstrated. In vivo, a single low-volume intratumoral administration of GO:BTZ complex shows an enhanced cytotoxic effect compared to free drug in two orthotopic GBM mouse models. This study provides evidence of the potential that thin and small GO sheets hold as flat nanoscale platforms for GBM treatment by increasing the bioavailable drug concentration locally, leading to an enhanced therapeutic effect.
Collapse
Affiliation(s)
- Paul S Sharp
- Nanomedicine Lab, Faculty of Biology, Medicine & Health, National Graphene Institute, University of Manchester, AV Hill Building, Manchester, M13 9PT, UK
| | - Maria Stylianou
- Nanomedicine Lab, Faculty of Biology, Medicine & Health, National Graphene Institute, University of Manchester, AV Hill Building, Manchester, M13 9PT, UK
| | - Luis M Arellano
- Catalan Institute of Nanoscience and Nanotechnology (ICN2), Campus UAB, Bellaterra, Barcelona, 08193, Spain
| | - Juliana C Neves
- Catalan Institute of Nanoscience and Nanotechnology (ICN2), Campus UAB, Bellaterra, Barcelona, 08193, Spain
| | - Alfredo M Gravagnuolo
- Nanomedicine Lab, Faculty of Biology, Medicine & Health, National Graphene Institute, University of Manchester, AV Hill Building, Manchester, M13 9PT, UK
| | - Abbie Dodd
- Nanomedicine Lab, Faculty of Biology, Medicine & Health, National Graphene Institute, University of Manchester, AV Hill Building, Manchester, M13 9PT, UK
| | - Katharine Barr
- Nanomedicine Lab, Faculty of Biology, Medicine & Health, National Graphene Institute, University of Manchester, AV Hill Building, Manchester, M13 9PT, UK
| | - Neus Lozano
- Catalan Institute of Nanoscience and Nanotechnology (ICN2), Campus UAB, Bellaterra, Barcelona, 08193, Spain
| | - Thomas Kisby
- Nanomedicine Lab, Faculty of Biology, Medicine & Health, National Graphene Institute, University of Manchester, AV Hill Building, Manchester, M13 9PT, UK
| | - Kostas Kostarelos
- Nanomedicine Lab, Faculty of Biology, Medicine & Health, National Graphene Institute, University of Manchester, AV Hill Building, Manchester, M13 9PT, UK.,Catalan Institute of Nanoscience and Nanotechnology (ICN2), Campus UAB, Bellaterra, Barcelona, 08193, Spain
| |
Collapse
|
14
|
Parker H, Gravagnuolo AM, Vranic S, Crica LE, Newman L, Carnell O, Bussy C, Dookie RS, Prestat E, Haigh SJ, Lozano N, Kostarelos K, MacDonald AS. Graphene oxide modulates dendritic cell ability to promote T cell activation and cytokine production. Nanoscale 2022; 14:17297-17314. [PMID: 36374249 DOI: 10.1039/d2nr02169b] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/16/2023]
Abstract
An important aspect of immunotherapy is the ability of dendritic cells (DCs) to prime T cell immunity, an approach that has yielded promising results in some early phase clinical trials. However, novel approaches are required to improve DC therapeutic efficacy by enhancing their uptake of, and activation by, disease relevant antigens. The carbon nano-material graphene oxide (GO) may provide a unique way to deliver antigen to innate immune cells and modify their ability to initiate effective adaptive immune responses. We have assessed whether GO of various lateral sizes affects DC activation and function in vitro and in vivo, including their ability to take up, process and present the well-defined model antigen ovalbumin (OVA). We have found that GO flakes are internalised by DCs, while having minimal effect on their viability, activation phenotype or cytokine production. Although adsorption of OVA protein to either small or large GO flakes promoted its uptake into DCs, large GO interfered with OVA processing. In terms of modulation of DC function, delivery of OVA via small GO flakes significantly enhanced DC ability to induce proliferation of OVA-specific CD4+ T cells, promoting granzyme B secretion in vitro. On the other hand, delivery of OVA via large GO flakes augmented DC ability to induce proliferation of OVA-specific CD8+ T cells, and their production of IFN-γ and granzyme B. Together, these data demonstrate the capacity of GO of different lateral dimensions to act as a promising delivery platform for DC modulation of distinct facets of the adaptive immune response, information that could be exploited for future development of targeted immunotherapies.
Collapse
Affiliation(s)
- Helen Parker
- The Lydia Becker Institute of Immunology and Inflammation, University of Manchester, UK.
| | - Alfredo Maria Gravagnuolo
- Nanomedicine Lab, University of Manchester, UK.
- National Graphene Institute, University of Manchester, UK
| | - Sandra Vranic
- Nanomedicine Lab, University of Manchester, UK.
- National Graphene Institute, University of Manchester, UK
| | - Livia Elena Crica
- Nanomedicine Lab, University of Manchester, UK.
- National Graphene Institute, University of Manchester, UK
| | - Leon Newman
- Nanomedicine Lab, University of Manchester, UK.
- National Graphene Institute, University of Manchester, UK
| | - Oliver Carnell
- The Lydia Becker Institute of Immunology and Inflammation, University of Manchester, UK.
| | - Cyrill Bussy
- The Lydia Becker Institute of Immunology and Inflammation, University of Manchester, UK.
- Nanomedicine Lab, University of Manchester, UK.
- National Graphene Institute, University of Manchester, UK
| | - Rebecca S Dookie
- The Lydia Becker Institute of Immunology and Inflammation, University of Manchester, UK.
| | - Eric Prestat
- School of Materials, University of Manchester, UK
- SuperSTEM Laboratory, SciTech Daresbury Campus, Daresbury, WA4 4AD, UK
| | - Sarah J Haigh
- National Graphene Institute, University of Manchester, UK
- School of Materials, University of Manchester, UK
| | - Neus Lozano
- Catalan Institute of Nanoscience and Nanotechnology (ICN2), CSIC and BIST, Campus UAB, Bellaterra, 08193 Barcelona, Spain
| | - Kostas Kostarelos
- Nanomedicine Lab, University of Manchester, UK.
- National Graphene Institute, University of Manchester, UK
- Catalan Institute of Nanoscience and Nanotechnology (ICN2), CSIC and BIST, Campus UAB, Bellaterra, 08193 Barcelona, Spain
| | - Andrew S MacDonald
- The Lydia Becker Institute of Immunology and Inflammation, University of Manchester, UK.
| |
Collapse
|
15
|
Hu CX, Read O, Shin Y, Chen Y, Wang J, Boyes M, Zeng N, Panigrahi A, Kostarelos K, Larrosa I, Vranic S, Casiraghi C. Effects of Lateral Size, Thickness, and Stabilizer Concentration on the Cytotoxicity of Defect-Free Graphene Nanosheets: Implications for Biological Applications. ACS Appl Nano Mater 2022; 5:12626-12636. [PMID: 36185165 PMCID: PMC9513747 DOI: 10.1021/acsanm.2c02403] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 06/01/2022] [Accepted: 08/25/2022] [Indexed: 06/16/2023]
Abstract
In this work, we apply liquid cascade centrifugation to highly concentrated graphene dispersions produced by liquid-phase exfoliation in water with an insoluble bis-pyrene stabilizer to obtain fractions containing nanosheets with different lateral size distributions. The concentration, stability, size, thickness, and the cytotoxicity profile are studied as a function of the initial stabilizer concentration for each fraction. Our results show that there is a critical initial amount of stabilizer (0.4 mg/mL) above which the dispersions show reduced concentration, stability, and biocompatibility, no matter the lateral size of the flakes.
Collapse
Affiliation(s)
- Chen-Xia Hu
- Department
of Chemistry, University of Manchester, Oxford Road, Manchester M13 9PL, UK
| | - Oliver Read
- Department
of Chemistry, University of Manchester, Oxford Road, Manchester M13 9PL, UK
| | - Yuyoung Shin
- Department
of Chemistry, University of Manchester, Oxford Road, Manchester M13 9PL, UK
| | - Yingxian Chen
- Nanomedicine
Lab, Faculty of Biology, Medicine and Health, AV Hill Building, University of Manchester, Manchester M13 9PL, UK
- National
Graphene Institute, University of Manchester, Booth Street East, Manchester M13 9PL, UK
| | - Jingjing Wang
- Department
of Chemistry, University of Manchester, Oxford Road, Manchester M13 9PL, UK
| | - Matthew Boyes
- Department
of Chemistry, University of Manchester, Oxford Road, Manchester M13 9PL, UK
| | - Niting Zeng
- Department
of Chemistry, University of Manchester, Oxford Road, Manchester M13 9PL, UK
| | - Adyasha Panigrahi
- Department
of Chemistry, University of Manchester, Oxford Road, Manchester M13 9PL, UK
| | - Kostas Kostarelos
- Nanomedicine
Lab, Faculty of Biology, Medicine and Health, AV Hill Building, University of Manchester, Manchester M13 9PL, UK
- National
Graphene Institute, University of Manchester, Booth Street East, Manchester M13 9PL, UK
- Catalan
Institute of Nanoscience and Nanotechnology (ICN2), UAB Campus Bellaterra, Barcelona 08193, Spain
| | - Igor Larrosa
- Department
of Chemistry, University of Manchester, Oxford Road, Manchester M13 9PL, UK
| | - Sandra Vranic
- Nanomedicine
Lab, Faculty of Biology, Medicine and Health, AV Hill Building, University of Manchester, Manchester M13 9PL, UK
- National
Graphene Institute, University of Manchester, Booth Street East, Manchester M13 9PL, UK
| | - Cinzia Casiraghi
- Department
of Chemistry, University of Manchester, Oxford Road, Manchester M13 9PL, UK
| |
Collapse
|
16
|
de Luna LAV, Loret T, Fordham A, Arshad A, Drummond M, Dodd A, Lozano N, Kostarelos K, Bussy C. Lung recovery from DNA damage induced by graphene oxide is dependent on size, dose and inflammation profile. Part Fibre Toxicol 2022; 19:62. [PMID: 36131347 PMCID: PMC9490925 DOI: 10.1186/s12989-022-00502-w] [Citation(s) in RCA: 6] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/30/2022] [Accepted: 09/06/2022] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND A key aspect of any new material safety assessment is the evaluation of their in vivo genotoxicity. Graphene oxide (GO) has been studied for many promising applications, but there are remaining concerns about its safety profile, especially after inhalation. Herein we tested whether GO lateral dimension, comparing micrometric (LGO) and nanometric (USGO) GO sheets, has a role in the formation of DNA double strand breaks in mouse lungs. We used spatial resolution and differential cell type analysis to measure DNA damages in both epithelial and immune cells, after either single or repeated exposure. RESULTS GO induced DNA damages were size and dose dependent, in both exposure scenario. After single exposure to a high dose, both USGO and LGO induced significant DNA damage in the lung parenchyma, but only during the acute phase response (p < 0.05 for USGO; p < 0.01 for LGO). This was followed by a fast lung recovery at day 7 and 28 for both GOs. When evaluating the chronic impact of GO after repeated exposure, only a high dose of LGO induced long-term DNA damages in lung alveolar epithelia (at 84 days, p < 0.05). Regardless of size, low dose GO did not induce any significant DNA damage after repeated exposure. A multiparametric correlation analysis of our repeated exposure data revealed that transient or persistent inflammation and oxidative stress were associated to either recovery or persistent DNA damages. For USGO, recovery from DNA damage was correlated to efficient recovery from acute inflammation (i.e., significant secretion of SAA3, p < 0.001; infiltration of neutrophils, p < 0.01). In contrast, the persistence of LGO in lungs was associated to a long-lasting presence of multinucleated macrophages (up to 84 days, p < 0.05), an underlying inflammation (IL-1α secretion up to 28 days, p < 0.05) and the presence of persistent DNA damages at 84 days. CONCLUSIONS Overall these results highlight the importance of the exposure scenario used. We showed that LGO was more genotoxic after repeated exposure than single exposure due to persistent lung inflammation. These findings are important in the context of human health risk assessment and toward establishing recommendations for a safe use of graphene based materials in the workplace.
Collapse
Affiliation(s)
- Luis Augusto Visani de Luna
- Nanomedicine Lab 2.0, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester, Manchester, M13 9PT, UK.,National Graphene Institute, The University of Manchester, Manchester, M13 9PL, UK.,Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester, Manchester, M13 9PT, UK
| | - Thomas Loret
- Nanomedicine Lab 2.0, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester, Manchester, M13 9PT, UK.,National Graphene Institute, The University of Manchester, Manchester, M13 9PL, UK.,Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester, Manchester, M13 9PT, UK
| | - Alexander Fordham
- Nanomedicine Lab 2.0, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester, Manchester, M13 9PT, UK.,National Graphene Institute, The University of Manchester, Manchester, M13 9PL, UK.,Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester, Manchester, M13 9PT, UK
| | - Atta Arshad
- Nanomedicine Lab 2.0, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester, Manchester, M13 9PT, UK.,National Graphene Institute, The University of Manchester, Manchester, M13 9PL, UK.,Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester, Manchester, M13 9PT, UK
| | - Matthew Drummond
- Nanomedicine Lab 2.0, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester, Manchester, M13 9PT, UK.,National Graphene Institute, The University of Manchester, Manchester, M13 9PL, UK
| | - Abbie Dodd
- Nanomedicine Lab 2.0, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester, Manchester, M13 9PT, UK.,National Graphene Institute, The University of Manchester, Manchester, M13 9PL, UK
| | - Neus Lozano
- Catalan Institute of Nanoscience and Nanotechnology (ICN2), CSIC and BIST, Campus UAB, Bellaterra, 08193, Barcelona, Spain
| | - Kostas Kostarelos
- Nanomedicine Lab 2.0, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester, Manchester, M13 9PT, UK.,National Graphene Institute, The University of Manchester, Manchester, M13 9PL, UK.,Catalan Institute of Nanoscience and Nanotechnology (ICN2), CSIC and BIST, Campus UAB, Bellaterra, 08193, Barcelona, Spain
| | - Cyrill Bussy
- Nanomedicine Lab 2.0, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester, Manchester, M13 9PT, UK. .,National Graphene Institute, The University of Manchester, Manchester, M13 9PL, UK. .,Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester, Manchester, M13 9PT, UK.
| |
Collapse
|
17
|
Fordham A, Bianco A, Lozano N, Kostarelos K, Bussy C. SOC-IV-01 Graphene oxide and hexagonal boron nitride nanosheets do not induce innate immune memory. Toxicol Lett 2022. [DOI: 10.1016/j.toxlet.2022.07.158] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
18
|
Loret T, de Luna LV, Lucarelli M, Fordham A, Lozano N, Bianco A, Kostarelos K, Bussy C. SOC-III-03 Pulmonary toxicity of graphene based materials is governed by size-dependant biodegradation and clearance in alveolar phagocytes. Toxicol Lett 2022. [DOI: 10.1016/j.toxlet.2022.07137] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]
|
19
|
Chortarea S, Kuru OC, Netkueakul W, Pelin M, Keshavan S, Song Z, Ma B, Gómes J, Abalos EV, Luna LAVD, Loret T, Fordham A, Drummond M, Kontis N, Anagnostopoulos G, Paterakis G, Cataldi P, Tubaro A, Galiotis C, Kinloch I, Fadeel B, Bussy C, Kostarelos K, Buerki-Thurnherr T, Prato M, Bianco A, Wick P. Hazard assessment of abraded thermoplastic composites reinforced with reduced graphene oxide. J Hazard Mater 2022; 435:129053. [PMID: 35650742 DOI: 10.1016/j.jhazmat.2022.129053] [Citation(s) in RCA: 15] [Impact Index Per Article: 7.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/13/2022] [Revised: 04/22/2022] [Accepted: 04/29/2022] [Indexed: 06/15/2023]
Abstract
Graphene-related materials (GRMs) are subject to intensive investigations and considerable progress has been made in recent years in terms of safety assessment. However, limited information is available concerning the hazard potential of GRM-containing products such as graphene-reinforced composites. In the present study, we conducted a comprehensive investigation of the potential biological effects of particles released through an abrasion process from reduced graphene oxide (rGO)-reinforced composites of polyamide 6 (PA6), a widely used engineered thermoplastic polymer, in comparison to as-produced rGO. First, a panel of well-established in vitro models, representative of the immune system and possible target organs such as the lungs, the gut, and the skin, was applied. Limited responses to PA6-rGO exposure were found in the different in vitro models. Only as-produced rGO induced substantial adverse effects, in particular in macrophages. Since inhalation of airborne materials is a key occupational concern, we then sought to test whether the in vitro responses noted for these materials would translate into adverse effects in vivo. To this end, the response at 1, 7 and 28 days after a single pulmonary exposure was evaluated in mice. In agreement with the in vitro data, PA6-rGO induced a modest and transient pulmonary inflammation, resolved by day 28. In contrast, rGO induced a longer-lasting, albeit moderate inflammation that did not lead to tissue remodeling within 28 days. Taken together, the present study suggests a negligible impact on human health under acute exposure conditions of GRM fillers such as rGO when released from composites at doses expected at the workplace.
Collapse
Affiliation(s)
- Savvina Chortarea
- Swiss Federal Laboratories for Materials Science and Technology (Empa), Laboratory for Particles-Biology Interactions, 9014 St. Gallen, Switzerland
| | - Ogul Can Kuru
- Swiss Federal Laboratories for Materials Science and Technology (Empa), Laboratory for Particles-Biology Interactions, 9014 St. Gallen, Switzerland
| | - Woranan Netkueakul
- Swiss Federal Laboratories for Materials Science and Technology (Empa), Laboratory for Particles-Biology Interactions, 9014 St. Gallen, Switzerland
| | - Marco Pelin
- Department of Life Sciences, University of Trieste, 34127 Trieste, Italy
| | - Sandeep Keshavan
- Nanosafety & Nanomedicine Laboratory, Institute of Environmental Medicine, Karolinska Institutet, 177 77 Stockholm, Sweden
| | - Zhengmei Song
- CNRS, Immunology, Immunopathology and Therapeutic Chemistry, UPR3572, University of Strasbourg, ISIS, 67000 Strasbourg, France
| | - Baojin Ma
- CNRS, Immunology, Immunopathology and Therapeutic Chemistry, UPR3572, University of Strasbourg, ISIS, 67000 Strasbourg, France
| | - Julio Gómes
- Avanzare Innovacion Tecnologica S.L. 26370 Navarrete, Spain
| | - Elvira Villaro Abalos
- Instituto de Tecnologías Químicas de La Rioja (InterQuímica), 26370 Navarrete, Spain
| | - Luis Augusto Visani de Luna
- Nanomedicine Lab, Faculty of Biology, Medicine & Health, University of Manchester, Manchester M13 9PT, United Kingdom; National Graphene Institute, University of Manchester, Manchester M13 9PL, United Kingdom; Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester M13 9PL, United Kingdom
| | - Thomas Loret
- Nanomedicine Lab, Faculty of Biology, Medicine & Health, University of Manchester, Manchester M13 9PT, United Kingdom; National Graphene Institute, University of Manchester, Manchester M13 9PL, United Kingdom; Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester M13 9PL, United Kingdom
| | - Alexander Fordham
- Nanomedicine Lab, Faculty of Biology, Medicine & Health, University of Manchester, Manchester M13 9PT, United Kingdom; National Graphene Institute, University of Manchester, Manchester M13 9PL, United Kingdom; Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester M13 9PL, United Kingdom
| | - Matthew Drummond
- Nanomedicine Lab, Faculty of Biology, Medicine & Health, University of Manchester, Manchester M13 9PT, United Kingdom; National Graphene Institute, University of Manchester, Manchester M13 9PL, United Kingdom
| | - Nikolaos Kontis
- Institute of Chemical Engineering Sciences, Foundation of Research and Technology-Hellas (FORTH/ICE-HT), 26504 Patras, Greece
| | - George Anagnostopoulos
- Institute of Chemical Engineering Sciences, Foundation of Research and Technology-Hellas (FORTH/ICE-HT), 26504 Patras, Greece
| | - George Paterakis
- Institute of Chemical Engineering Sciences, Foundation of Research and Technology-Hellas (FORTH/ICE-HT), 26504 Patras, Greece
| | - Pietro Cataldi
- National Graphene Institute, University of Manchester, Manchester M13 9PL, United Kingdom; Department of Materials, University of Manchester, Manchester M13 9PL, United Kingdom
| | - Aurelia Tubaro
- Department of Life Sciences, University of Trieste, 34127 Trieste, Italy
| | - Costas Galiotis
- Institute of Chemical Engineering Sciences, Foundation of Research and Technology-Hellas (FORTH/ICE-HT), 26504 Patras, Greece; Department of Chemical Engineering, University of Patras, 26504 Patras, Greece
| | - Ian Kinloch
- National Graphene Institute, University of Manchester, Manchester M13 9PL, United Kingdom; Department of Materials, University of Manchester, Manchester M13 9PL, United Kingdom
| | - Bengt Fadeel
- Nanosafety & Nanomedicine Laboratory, Institute of Environmental Medicine, Karolinska Institutet, 177 77 Stockholm, Sweden
| | - Cyrill Bussy
- Nanomedicine Lab, Faculty of Biology, Medicine & Health, University of Manchester, Manchester M13 9PT, United Kingdom; National Graphene Institute, University of Manchester, Manchester M13 9PL, United Kingdom; Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester M13 9PL, United Kingdom
| | - Kostas Kostarelos
- Nanomedicine Lab, Faculty of Biology, Medicine & Health, University of Manchester, Manchester M13 9PT, United Kingdom; National Graphene Institute, University of Manchester, Manchester M13 9PL, United Kingdom; Catalan Institute of Nanoscience and Nanotechnology (ICN2), and Barcelona Institute of Science and Technology (BIST), Barcelona 08193, Spain
| | - Tina Buerki-Thurnherr
- Swiss Federal Laboratories for Materials Science and Technology (Empa), Laboratory for Particles-Biology Interactions, 9014 St. Gallen, Switzerland
| | - Maurizio Prato
- Department of Chemical and Pharmaceutical Sciences, University of Trieste, 34127 Trieste, Italy; Center for Cooperative Research in Biomaterials (CIC biomaGUNE), Basque Research and Technology Alliance (BRTA), 20014 Donostia San Sebastián, Spain; Basque Foundation for Science (IKERBASQUE), 48013 Bilbao, Spain
| | - Alberto Bianco
- CNRS, Immunology, Immunopathology and Therapeutic Chemistry, UPR3572, University of Strasbourg, ISIS, 67000 Strasbourg, France
| | - Peter Wick
- Swiss Federal Laboratories for Materials Science and Technology (Empa), Laboratory for Particles-Biology Interactions, 9014 St. Gallen, Switzerland.
| |
Collapse
|
20
|
Gardner L, Kostarelos K, Mallick P, Dive C, Hadjidemetriou M. Nano-omics: nanotechnology-based multidimensional harvesting of the blood-circulating cancerome. Nat Rev Clin Oncol 2022; 19:551-561. [PMID: 35739399 DOI: 10.1038/s41571-022-00645-x] [Citation(s) in RCA: 13] [Impact Index Per Article: 6.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 05/10/2022] [Indexed: 02/08/2023]
Abstract
Over the past decade, the development of 'simple' blood tests that enable cancer screening, diagnosis or monitoring and facilitate the design of personalized therapies without the need for invasive tumour biopsy sampling has been a core ambition in cancer research. Data emerging from ongoing biomarker development efforts indicate that multiple markers, used individually or as part of a multimodal panel, are required to enhance the sensitivity and specificity of assays for early stage cancer detection. The discovery of cancer-associated molecular alterations that are reflected in blood at multiple dimensions (genome, epigenome, transcriptome, proteome and metabolome) and integration of the resultant multi-omics data have the potential to uncover novel biomarkers as well as to further elucidate the underlying molecular pathways. Herein, we review key advances in multi-omics liquid biopsy approaches and introduce the 'nano-omics' paradigm: the development and utilization of nanotechnology tools for the enrichment and subsequent omics analysis of the blood-circulating cancerome.
Collapse
Affiliation(s)
- Lois Gardner
- Nanomedicine Lab, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK
- Cancer Research UK Manchester Institute Cancer Biomarker Centre, The University of Manchester, Manchester, UK
| | - Kostas Kostarelos
- Nanomedicine Lab, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK
- Catalan Institute of Nanoscience & Nanotechnology (ICN2), UAB Campus, Barcelona, Spain
| | - Parag Mallick
- Canary Center at Stanford for Cancer Early Detection, Stanford University, California, USA
| | - Caroline Dive
- Cancer Research UK Manchester Institute Cancer Biomarker Centre, The University of Manchester, Manchester, UK
| | - Marilena Hadjidemetriou
- Nanomedicine Lab, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.
| |
Collapse
|
21
|
Hills KE, Kostarelos K, Wykes RC. Converging Mechanisms of Epileptogenesis and Their Insight in Glioblastoma. Front Mol Neurosci 2022; 15:903115. [PMID: 35832394 PMCID: PMC9271928 DOI: 10.3389/fnmol.2022.903115] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/23/2022] [Accepted: 05/25/2022] [Indexed: 12/15/2022] Open
Abstract
Glioblastoma (GBM) is the most common and advanced form of primary malignant tumor occurring in the adult central nervous system, and it is frequently associated with epilepsy, a debilitating comorbidity. Seizures are observed both pre- and post-surgical resection, indicating that several pathophysiological mechanisms are shared but also prompting questions about how the process of epileptogenesis evolves throughout GBM progression. Molecular mutations commonly seen in primary GBM, i.e., in PTEN and p53, and their associated downstream effects are known to influence seizure likelihood. Similarly, various intratumoral mechanisms, such as GBM-induced blood-brain barrier breakdown and glioma-immune cell interactions within the tumor microenvironment are also cited as contributing to network hyperexcitability. Substantial alterations to peri-tumoral glutamate and chloride transporter expressions, as well as widespread dysregulation of GABAergic signaling are known to confer increased epileptogenicity and excitotoxicity. The abnormal characteristics of GBM alter neuronal network function to result in metabolically vulnerable and hyperexcitable peri-tumoral tissue, properties the tumor then exploits to favor its own growth even post-resection. It is evident that there is a complex, dynamic interplay between GBM and epilepsy that promotes the progression of both pathologies. This interaction is only more complicated by the concomitant presence of spreading depolarization (SD). The spontaneous, high-frequency nature of GBM-associated epileptiform activity and SD-associated direct current (DC) shifts require technologies capable of recording brain signals over a wide bandwidth, presenting major challenges for comprehensive electrophysiological investigations. This review will initially provide a detailed examination of the underlying mechanisms that promote network hyperexcitability in GBM. We will then discuss how an investigation of these pathologies from a network level, and utilization of novel electrophysiological tools, will yield a more-effective, clinically-relevant understanding of GBM-related epileptogenesis. Further to this, we will evaluate the clinical relevance of current preclinical research and consider how future therapeutic advancements may impact the bidirectional relationship between GBM, SDs, and seizures.
Collapse
Affiliation(s)
- Kate E. Hills
- Nanomedicine Lab, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom
| | - Kostas Kostarelos
- Nanomedicine Lab, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom
- Catalan Institute for Nanoscience and Nanotechnology (ICN2), Edifici ICN2, Campus UAB, Barcelona, Spain
| | - Robert C. Wykes
- Nanomedicine Lab, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom
- Department of Clinical and Experimental Epilepsy, UCL Queen Square Institute of Neurology, London, United Kingdom
- *Correspondence: Robert C. Wykes
| |
Collapse
|
22
|
Kisby T, Yilmazer A, Kostarelos K. Author Correction: Reasons for success and lessons learnt from nanoscale vaccines against COVID-19. Nat Nanotechnol 2022; 17:671. [PMID: 35551244 PMCID: PMC9097148 DOI: 10.1038/s41565-022-01141-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/15/2023]
Affiliation(s)
- Thomas Kisby
- Nanomedicine Lab, Faculty of Biology, Medicine & Health, University of Manchester, Manchester, UK
- National Graphene Institute, University of Manchester, Manchester, UK
| | - Açelya Yilmazer
- Stem Cell Institute, Ankara University, Ankara, Turkey
- Department of Biomedical Engineering, Ankara University, Ankara, Turkey
| | - Kostas Kostarelos
- Nanomedicine Lab, Faculty of Biology, Medicine & Health, University of Manchester, Manchester, UK.
- National Graphene Institute, University of Manchester, Manchester, UK.
- Catalan Institute of Nanoscience and Nanotechnology (ICN2), UAB Campus Bellaterra, Barcelona, Spain.
| |
Collapse
|
23
|
Loret T, de Luna LAV, Fordham A, Arshad A, Barr K, Lozano N, Kostarelos K, Bussy C. Innate but Not Adaptive Immunity Regulates Lung Recovery from Chronic Exposure to Graphene Oxide Nanosheets. Adv Sci (Weinh) 2022; 9:e2104559. [PMID: 35166457 PMCID: PMC9008410 DOI: 10.1002/advs.202104559] [Citation(s) in RCA: 10] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/14/2021] [Revised: 12/21/2021] [Indexed: 05/05/2023]
Abstract
Graphene has drawn a lot of interest in the material community due to unique physicochemical properties. Owing to a high surface area to volume ratio and free oxygen groups, the oxidized derivative, graphene oxide (GO) has promising potential as a drug delivery system. Here, the lung tolerability of two distinct GO varying in lateral dimensions is investigated, to reveal the most suitable candidate platform for pulmonary drug delivery. Following repeated chronic pulmonary exposure of mice to GO sheet suspensions, the innate and adaptive immune responses are studied. An acute and transient influx of neutrophils and eosinophils in the alveolar space, together with the replacement of alveolar macrophages by interstitial ones and a significant activation toward anti-inflammatory subsets, are found for both GO materials. Micrometric GO give rise to persistent multinucleated macrophages and granulomas. However, neither adaptive immune response nor lung tissue remodeling are induced after exposure to micrometric GO. Concurrently, milder effects and faster tissue recovery, both associated to a faster clearance from the respiratory tract, are found for nanometric GO, suggesting a greater lung tolerability. Taken together, these results highlight the importance of dimensions in the design of biocompatible 2D materials for pulmonary drug delivery system.
Collapse
Affiliation(s)
- Thomas Loret
- Nanomedicine LabFaculty of Biology, Medicine and HealthThe University of ManchesterManchester Academic Health Science CentreManchesterM13 9PTUK
- National Graphene InstituteThe University of ManchesterManchesterM13 9PLUK
- Lydia Becker Institute of Immunology and InflammationFaculty of Biology, Medicine and HealthThe University of ManchesterManchester Academic Health Science CentreManchesterM13 9PTUK
| | - Luis Augusto Visani de Luna
- Nanomedicine LabFaculty of Biology, Medicine and HealthThe University of ManchesterManchester Academic Health Science CentreManchesterM13 9PTUK
- National Graphene InstituteThe University of ManchesterManchesterM13 9PLUK
- Lydia Becker Institute of Immunology and InflammationFaculty of Biology, Medicine and HealthThe University of ManchesterManchester Academic Health Science CentreManchesterM13 9PTUK
| | - Alexander Fordham
- Nanomedicine LabFaculty of Biology, Medicine and HealthThe University of ManchesterManchester Academic Health Science CentreManchesterM13 9PTUK
- National Graphene InstituteThe University of ManchesterManchesterM13 9PLUK
- Lydia Becker Institute of Immunology and InflammationFaculty of Biology, Medicine and HealthThe University of ManchesterManchester Academic Health Science CentreManchesterM13 9PTUK
| | - Atta Arshad
- Nanomedicine LabFaculty of Biology, Medicine and HealthThe University of ManchesterManchester Academic Health Science CentreManchesterM13 9PTUK
- National Graphene InstituteThe University of ManchesterManchesterM13 9PLUK
- Lydia Becker Institute of Immunology and InflammationFaculty of Biology, Medicine and HealthThe University of ManchesterManchester Academic Health Science CentreManchesterM13 9PTUK
| | - Katharine Barr
- Nanomedicine LabFaculty of Biology, Medicine and HealthThe University of ManchesterManchester Academic Health Science CentreManchesterM13 9PTUK
- National Graphene InstituteThe University of ManchesterManchesterM13 9PLUK
| | - Neus Lozano
- Catalan Institute of Nanoscience and Nanotechnology (ICN2)CSIC and The Barcelona Institute of Science and Technology (BIST)Campus UABBellaterraBarcelona08193Spain
| | - Kostas Kostarelos
- Nanomedicine LabFaculty of Biology, Medicine and HealthThe University of ManchesterManchester Academic Health Science CentreManchesterM13 9PTUK
- National Graphene InstituteThe University of ManchesterManchesterM13 9PLUK
- Catalan Institute of Nanoscience and Nanotechnology (ICN2)CSIC and The Barcelona Institute of Science and Technology (BIST)Campus UABBellaterraBarcelona08193Spain
| | - Cyrill Bussy
- Nanomedicine LabFaculty of Biology, Medicine and HealthThe University of ManchesterManchester Academic Health Science CentreManchesterM13 9PTUK
- National Graphene InstituteThe University of ManchesterManchesterM13 9PLUK
- Lydia Becker Institute of Immunology and InflammationFaculty of Biology, Medicine and HealthThe University of ManchesterManchester Academic Health Science CentreManchesterM13 9PTUK
| |
Collapse
|
24
|
Bonaccini Calia A, Masvidal-Codina E, Smith TM, Schäfer N, Rathore D, Rodríguez-Lucas E, Illa X, De la Cruz JM, Del Corro E, Prats-Alfonso E, Viana D, Bousquet J, Hébert C, Martínez-Aguilar J, Sperling JR, Drummond M, Halder A, Dodd A, Barr K, Savage S, Fornell J, Sort J, Guger C, Villa R, Kostarelos K, Wykes RC, Guimerà-Brunet A, Garrido JA. Full-bandwidth electrophysiology of seizures and epileptiform activity enabled by flexible graphene microtransistor depth neural probes. Nat Nanotechnol 2022; 17:301-309. [PMID: 34937934 DOI: 10.1038/s41565-021-01041-9] [Citation(s) in RCA: 32] [Impact Index Per Article: 16.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/14/2020] [Accepted: 11/02/2021] [Indexed: 06/14/2023]
Abstract
Mapping the entire frequency bandwidth of brain electrophysiological signals is of paramount importance for understanding physiological and pathological states. The ability to record simultaneously DC-shifts, infraslow oscillations (<0.1 Hz), typical local field potentials (0.1-80 Hz) and higher frequencies (80-600 Hz) using the same recording site would particularly benefit preclinical epilepsy research and could provide clinical biomarkers for improved seizure onset zone delineation. However, commonly used metal microelectrode technology suffers from instabilities that hamper the high fidelity of DC-coupled recordings, which are needed to access signals of very low frequency. In this study we used flexible graphene depth neural probes (gDNPs), consisting of a linear array of graphene microtransistors, to concurrently record DC-shifts and high-frequency neuronal activity in awake rodents. We show here that gDNPs can reliably record and map with high spatial resolution seizures, pre-ictal DC-shifts and seizure-associated spreading depolarizations together with higher frequencies through the cortical laminae to the hippocampus in a mouse model of chemically induced seizures. Moreover, we demonstrate the functionality of chronically implanted devices over 10 weeks by recording with high fidelity spontaneous spike-wave discharges and associated infraslow oscillations in a rat model of absence epilepsy. Altogether, our work highlights the suitability of this technology for in vivo electrophysiology research, and in particular epilepsy research, by allowing stable and chronic DC-coupled recordings.
Collapse
Affiliation(s)
- Andrea Bonaccini Calia
- Catalan Institute of Nanoscience and Nanotechnology, CSIC and The Barcelona Institute of Science and Technology, Campus UAB, Bellaterra, Spain
| | - Eduard Masvidal-Codina
- Institut de Microelectrònica de Barcelona, IMB-CNM (CSIC), Bellaterra, Spain
- Centro de Investigación Biomédica en Red en Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Madrid, Spain
| | - Trevor M Smith
- Department of Clinical and Experimental Epilepsy, Queen Square Institute of Neurology, University College London, London, UK
| | - Nathan Schäfer
- Catalan Institute of Nanoscience and Nanotechnology, CSIC and The Barcelona Institute of Science and Technology, Campus UAB, Bellaterra, Spain
| | - Daman Rathore
- Department of Clinical and Experimental Epilepsy, Queen Square Institute of Neurology, University College London, London, UK
| | - Elisa Rodríguez-Lucas
- Catalan Institute of Nanoscience and Nanotechnology, CSIC and The Barcelona Institute of Science and Technology, Campus UAB, Bellaterra, Spain
| | - Xavi Illa
- Institut de Microelectrònica de Barcelona, IMB-CNM (CSIC), Bellaterra, Spain
- Centro de Investigación Biomédica en Red en Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Madrid, Spain
| | - Jose M De la Cruz
- Catalan Institute of Nanoscience and Nanotechnology, CSIC and The Barcelona Institute of Science and Technology, Campus UAB, Bellaterra, Spain
| | - Elena Del Corro
- Catalan Institute of Nanoscience and Nanotechnology, CSIC and The Barcelona Institute of Science and Technology, Campus UAB, Bellaterra, Spain
| | - Elisabet Prats-Alfonso
- Institut de Microelectrònica de Barcelona, IMB-CNM (CSIC), Bellaterra, Spain
- Centro de Investigación Biomédica en Red en Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Madrid, Spain
| | - Damià Viana
- Catalan Institute of Nanoscience and Nanotechnology, CSIC and The Barcelona Institute of Science and Technology, Campus UAB, Bellaterra, Spain
| | - Jessica Bousquet
- Catalan Institute of Nanoscience and Nanotechnology, CSIC and The Barcelona Institute of Science and Technology, Campus UAB, Bellaterra, Spain
| | - Clement Hébert
- Catalan Institute of Nanoscience and Nanotechnology, CSIC and The Barcelona Institute of Science and Technology, Campus UAB, Bellaterra, Spain
| | - Javier Martínez-Aguilar
- Institut de Microelectrònica de Barcelona, IMB-CNM (CSIC), Bellaterra, Spain
- Centro de Investigación Biomédica en Red en Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Madrid, Spain
| | - Justin R Sperling
- Catalan Institute of Nanoscience and Nanotechnology, CSIC and The Barcelona Institute of Science and Technology, Campus UAB, Bellaterra, Spain
| | - Matthew Drummond
- Nanomedicine Lab, National Graphene Institute and Faculty of Biology Medicine and Health, University of Manchester, Manchester, UK
| | - Arnab Halder
- Nanomedicine Lab, National Graphene Institute and Faculty of Biology Medicine and Health, University of Manchester, Manchester, UK
| | - Abbie Dodd
- Nanomedicine Lab, National Graphene Institute and Faculty of Biology Medicine and Health, University of Manchester, Manchester, UK
| | - Katharine Barr
- Nanomedicine Lab, National Graphene Institute and Faculty of Biology Medicine and Health, University of Manchester, Manchester, UK
| | - Sinead Savage
- Nanomedicine Lab, National Graphene Institute and Faculty of Biology Medicine and Health, University of Manchester, Manchester, UK
| | - Jordina Fornell
- Departament de Fisica, Universitat Autonoma de Barcelona, Barcelona, Spain
| | - Jordi Sort
- Departament de Fisica, Universitat Autonoma de Barcelona, Barcelona, Spain
- Institució Catalana de Recerca i Estudis Avançats, Barcelona, Spain
| | - Christoph Guger
- g.tec medical engineering, Guger Technologies, Schiedlberg, Austria
| | - Rosa Villa
- Institut de Microelectrònica de Barcelona, IMB-CNM (CSIC), Bellaterra, Spain
- Centro de Investigación Biomédica en Red en Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Madrid, Spain
| | - Kostas Kostarelos
- Catalan Institute of Nanoscience and Nanotechnology, CSIC and The Barcelona Institute of Science and Technology, Campus UAB, Bellaterra, Spain
- Nanomedicine Lab, National Graphene Institute and Faculty of Biology Medicine and Health, University of Manchester, Manchester, UK
| | - Rob C Wykes
- Department of Clinical and Experimental Epilepsy, Queen Square Institute of Neurology, University College London, London, UK.
- Nanomedicine Lab, National Graphene Institute and Faculty of Biology Medicine and Health, University of Manchester, Manchester, UK.
| | - Anton Guimerà-Brunet
- Institut de Microelectrònica de Barcelona, IMB-CNM (CSIC), Bellaterra, Spain.
- Centro de Investigación Biomédica en Red en Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Madrid, Spain.
| | - Jose A Garrido
- Catalan Institute of Nanoscience and Nanotechnology, CSIC and The Barcelona Institute of Science and Technology, Campus UAB, Bellaterra, Spain.
- Institució Catalana de Recerca i Estudis Avançats, Barcelona, Spain.
| |
Collapse
|
25
|
Al-Ahmady ZS, Dickie BR, Aldred I, Jasim DA, Barrington J, Haley M, Lemarchand E, Coutts G, Kaur S, Bates J, Curran S, Goddard R, Walker M, Parry-jones A, Kostarelos K, Allan SM. Selective brain entry of lipid nanoparticles in haemorrhagic stroke is linked to biphasic blood-brain barrier disruption. Am J Cancer Res 2022; 12:4477-4497. [PMID: 35832077 PMCID: PMC9254235 DOI: 10.7150/thno.72167] [Citation(s) in RCA: 8] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/18/2022] [Accepted: 04/29/2022] [Indexed: 11/05/2022] Open
|
26
|
Al-Jamal WT, Kostarelos K. Mild hyperthermia accelerates doxorubicin clearance from tumour-extravasated temperature-sensitive liposomes. Nanotheranostics 2022; 6:230-242. [PMID: 35145834 PMCID: PMC8824668 DOI: 10.7150/ntno.61280] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/05/2021] [Accepted: 12/16/2021] [Indexed: 11/05/2022] Open
Abstract
Mild hyperthermia (HT) (40-43 °C) has been combined with temperature-sensitive liposomes (TSL), offering on-demand drug release for increased drug bioavailability and reduced systemic toxicity. Different HT regimens have been applied to trigger liposome drug release in the blood vessels (intravascular) of heated tumours or following tumour extravasation (interstitial). The present study systematically assessed the in vivo doxorubicin (Dox) release and therapeutic efficacy of Dox-loaded TSL with different release profiles. Low temperature-sensitive liposomes (LTSL-Dox), traditional-temperature-sensitive liposomes (TTSL-Dox), and non-temperature-sensitive liposomes (NTSL-Dox) were combined with a single or two HT in different tumour models (murine melanoma B16F10 tumour and human breast MDA-MB-435). The efficacy of each treatment was assessed by monitor tumour growth and mice survival. The level of Dox in tumour tissues was quantified using 14C-Dox and liquid scintillation while Dox release was assessed using live imaging and confocal laser scanning microscopy. Applying a second HT to release Dox from extravasated TTSL-Dox was not therapeutically superior to single HT application due to Dox clearance from the extravasated TTSL-Dox. Our findings revealed that enhanced blood perfusion in heated tumours during the second water bath HT could be seen as a hurdle for TTSL-Dox's anticancer efficacy, where the systemic toxicity of the redistributed Dox from the tumour tissues could be potentiated.
Collapse
|
27
|
Jasim DA, Newman L, Rodrigues AF, Vacchi IA, Lucherelli MA, Lozano N, Ménard-Moyon C, Bianco A, Kostarelos K. The impact of graphene oxide sheet lateral dimensions on their pharmacokinetic and tissue distribution profiles in mice. J Control Release 2021; 338:330-340. [PMID: 34418522 DOI: 10.1016/j.jconrel.2021.08.028] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/02/2020] [Revised: 08/11/2021] [Accepted: 08/16/2021] [Indexed: 10/20/2022]
Abstract
Although the use of graphene and 2-dimensional (2D) materials in biomedicine has been explored for over a decade now, there are still significant knowledge gaps regarding the fate of these materials upon interaction with living systems. Here, the pharmacokinetic profile of graphene oxide (GO) sheets of three different lateral dimensions was studied. The GO materials were functionalized with a PEGylated DOTA (1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid), a radiometal chelating agent for radioisotope attachment for single photon emission computed tomography (SPECT/CT) imaging. Our results revealed that GO materials with three distinct size distributions, large (l-GO-DOTA), small (s-GO-DOTA) and ultra-small (us-GO-DOTA), were sequestered by the spleen and liver. Significant accumulation of the large material (l-GO-DOTA) in the lungs was also observed, unlike the other two materials. Interestingly, there was extensive urinary excretion of all three GO nanomaterials indicating that urinary excretion of these structures was not affected by lateral dimensions. Comparing with previous studies, we believe that the thickness of layered nanomaterials is the predominant factor that governs their excretion rather than lateral size. However, the rate of urinary excretion was affected by lateral size, with large GO excreting at slower rates. This study provides better understanding of 2D materials in vivo behaviour with varying structural features.
Collapse
Affiliation(s)
- Dhifaf A Jasim
- Nanomedicine Lab, National Graphene Institute, Faculty of Biology, Medicine & Health, University of Manchester, AV Hill Building, Manchester M13 9PT, United Kingdom
| | - Leon Newman
- Nanomedicine Lab, National Graphene Institute, Faculty of Biology, Medicine & Health, University of Manchester, AV Hill Building, Manchester M13 9PT, United Kingdom
| | - Artur Filipe Rodrigues
- Nanomedicine Lab, National Graphene Institute, Faculty of Biology, Medicine & Health, University of Manchester, AV Hill Building, Manchester M13 9PT, United Kingdom
| | - Isabella A Vacchi
- CNRS, Immunology, Immunopathology and Therapeutic Chemistry, UPR3572, University of Strasbourg, Strasbourg 67000, France
| | - Matteo A Lucherelli
- CNRS, Immunology, Immunopathology and Therapeutic Chemistry, UPR3572, University of Strasbourg, Strasbourg 67000, France
| | - Neus Lozano
- Nanomedicine Lab, National Graphene Institute, Faculty of Biology, Medicine & Health, University of Manchester, AV Hill Building, Manchester M13 9PT, United Kingdom; Catalan Institute of Nanoscience and Nanotechnology (ICN2), CSIC and BIST, Campus UAB, Bellaterra, 08193 Barcelona, Spain
| | - Cécilia Ménard-Moyon
- CNRS, Immunology, Immunopathology and Therapeutic Chemistry, UPR3572, University of Strasbourg, Strasbourg 67000, France
| | - Alberto Bianco
- CNRS, Immunology, Immunopathology and Therapeutic Chemistry, UPR3572, University of Strasbourg, Strasbourg 67000, France
| | - Kostas Kostarelos
- Nanomedicine Lab, National Graphene Institute, Faculty of Biology, Medicine & Health, University of Manchester, AV Hill Building, Manchester M13 9PT, United Kingdom; Catalan Institute of Nanoscience and Nanotechnology (ICN2), CSIC and BIST, Campus UAB, Bellaterra, 08193 Barcelona, Spain.
| |
Collapse
|
28
|
Tringides CM, Vachicouras N, de Lázaro I, Wang H, Trouillet A, Seo BR, Elosegui-Artola A, Fallegger F, Shin Y, Casiraghi C, Kostarelos K, Lacour SP, Mooney DJ. Viscoelastic surface electrode arrays to interface with viscoelastic tissues. Nat Nanotechnol 2021; 16:1019-1029. [PMID: 34140673 PMCID: PMC9233755 DOI: 10.1038/s41565-021-00926-z] [Citation(s) in RCA: 92] [Impact Index Per Article: 30.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/30/2020] [Accepted: 05/05/2021] [Indexed: 05/10/2023]
Abstract
Living tissues are non-linearly elastic materials that exhibit viscoelasticity and plasticity. Man-made, implantable bioelectronic arrays mainly rely on rigid or elastic encapsulation materials and stiff films of ductile metals that can be manipulated with microscopic precision to offer reliable electrical properties. In this study, we have engineered a surface microelectrode array that replaces the traditional encapsulation and conductive components with viscoelastic materials. Our array overcomes previous limitations in matching the stiffness and relaxation behaviour of soft biological tissues by using hydrogels as the outer layers. We have introduced a hydrogel-based conductor made from an ionically conductive alginate matrix enhanced with carbon nanomaterials, which provide electrical percolation even at low loading fractions. Our combination of conducting and insulating viscoelastic materials, with top-down manufacturing, allows for the fabrication of electrode arrays compatible with standard electrophysiology platforms. Our arrays intimately conform to the convoluted surface of the heart or brain cortex and offer promising bioengineering applications for recording and stimulation.
Collapse
Affiliation(s)
- Christina M Tringides
- Harvard Program in Biophysics, Harvard University, Cambridge, MA, USA
- Harvard-MIT Division in Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, MA, USA
- Wyss Institute for Biologically Inspired Engineering, Harvard University, Cambridge, MA, USA
| | - Nicolas Vachicouras
- Laboratory for Soft Bioelectronic Interfaces, Institute of Microengineering, Institute of Bioengineering, Centre for Neuroprosthetics, École Polytechnique Fédérale de Lausanne, Geneva, Switzerland
| | - Irene de Lázaro
- Wyss Institute for Biologically Inspired Engineering, Harvard University, Cambridge, MA, USA
- John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA, USA
| | - Hua Wang
- Wyss Institute for Biologically Inspired Engineering, Harvard University, Cambridge, MA, USA
- John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA, USA
| | - Alix Trouillet
- Laboratory for Soft Bioelectronic Interfaces, Institute of Microengineering, Institute of Bioengineering, Centre for Neuroprosthetics, École Polytechnique Fédérale de Lausanne, Geneva, Switzerland
| | - Bo Ri Seo
- Wyss Institute for Biologically Inspired Engineering, Harvard University, Cambridge, MA, USA
- John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA, USA
| | - Alberto Elosegui-Artola
- Wyss Institute for Biologically Inspired Engineering, Harvard University, Cambridge, MA, USA
- John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA, USA
- Institute for Bioengineering of Catalonia, Barcelona, Spain
| | - Florian Fallegger
- Laboratory for Soft Bioelectronic Interfaces, Institute of Microengineering, Institute of Bioengineering, Centre for Neuroprosthetics, École Polytechnique Fédérale de Lausanne, Geneva, Switzerland
| | - Yuyoung Shin
- Department of Chemistry, The University of Manchester, Manchester, UK
| | - Cinzia Casiraghi
- Department of Chemistry, The University of Manchester, Manchester, UK
| | - Kostas Kostarelos
- Nanomedicine Lab, National Graphene Institute and Faculty of Biology, Medicine & Health, The University of Manchester, Manchester, UK
- Catalan Institute of Nanoscience and Nanotechnology (ICN2), Bellaterra, Barcelona, Spain
| | - Stéphanie P Lacour
- Laboratory for Soft Bioelectronic Interfaces, Institute of Microengineering, Institute of Bioengineering, Centre for Neuroprosthetics, École Polytechnique Fédérale de Lausanne, Geneva, Switzerland
| | - David J Mooney
- Wyss Institute for Biologically Inspired Engineering, Harvard University, Cambridge, MA, USA.
- John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA, USA.
| |
Collapse
|
29
|
Affiliation(s)
- Thomas Kisby
- Nanomedicine Lab, Faculty of Biology, Medicine & Health, University of Manchester, Manchester, UK
- National Graphene Institute, University of Manchester, Manchester, UK
| | - Açelya Yilmazer
- Stem Cell Institute, Ankara University, Ankara, Turkey
- Department of Biomedical Engineering, Ankara University, Ankara, Turkey
| | - Kostas Kostarelos
- Nanomedicine Lab, Faculty of Biology, Medicine & Health, University of Manchester, Manchester, UK.
- National Graphene Institute, University of Manchester, Manchester, UK.
- Catalan Institute of Nanoscience and Nanotechnology (ICN2), UAB Campus Bellaterra, Barcelona, Spain.
| |
Collapse
|
30
|
Chen Y, Rivers-Auty J, Crică LE, Barr K, Rosano V, Arranz AE, Loret T, Spiller D, Bussy C, Kostarelos K, Vranic S. Dynamic interactions and intracellular fate of label-free, thin graphene oxide sheets within mammalian cells: role of lateral sheet size. Nanoscale Adv 2021; 3:4166-4185. [PMID: 36132849 PMCID: PMC9419297 DOI: 10.1039/d1na00133g] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 02/19/2021] [Accepted: 05/09/2021] [Indexed: 06/16/2023]
Abstract
Graphene oxide (GO) holds great potential for biomedical applications, however fundamental understanding of the way it interacts with biological systems is still lacking even though it is essential for successful clinical translation. In this study, we exploit intrinsic fluorescent properties of thin GO sheets to establish the relationship between lateral dimensions of the material, its cellular uptake mechanisms and intracellular fate over time. Label-free GO with distinct lateral dimensions, small (s-GO) and ultra-small (us-GO) were thoroughly characterised both in water and in biologically relevant cell culture medium. Interactions of the material with a range of non-phagocytic mammalian cell lines (BEAS-2B, NIH/3T3, HaCaT, 293T) were studied using a combination of complementary analytical techniques (confocal microscopy, flow cytometry and TEM). The uptake mechanism was initially interrogated using a range of pharmaceutical inhibitors and validated using polystyrene beads of different diameters (0.1 and 1 μm). Subsequently, RNA-Seq was used to follow the changes in the uptake mechanism used to internalize s-GO flakes over time. Regardless of lateral dimensions, both types of GO were found to interact with the plasma membrane and to be internalized by a panel of cell lines studied. However, s-GO was internalized mainly via macropinocytosis while us-GO was mainly internalized via clathrin- and caveolae-mediated endocytosis. Importantly, we report the shift from macropinocytosis to clathrin-dependent endocytosis in the uptake of s-GO at 24 h, mediated by upregulation of mTORC1/2 pathway. Finally, we show that both s-GO and us-GO terminate in lysosomal compartments for up to 48 h. Our results offer an insight into the mechanism of interaction of GO with non-phagocytic cell lines over time that can be exploited for the design of biomedically-applicable 2D transport systems.
Collapse
Affiliation(s)
- Yingxian Chen
- Nanomedicine Lab, Faculty of Biology, Medicine and Health, The University of Manchester AV Hill Building Manchester M13 9PT UK
- National Graphene Institute, The University of Manchester Booth Street East Manchester M13 9PL UK
| | - Jack Rivers-Auty
- Division of Neuroscience and Experimental Psychology, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester AV Hill Building, Oxford Road Manchester M13 9PT UK
- Lydia Becker Institute of Immunology and Inflammation, University of Manchester Manchester M13 9PT UK
- School of Medicine, College of Health and Medicine, University of Tasmania Hobart Tasmania Australia
| | - Livia Elena Crică
- Nanomedicine Lab, Faculty of Biology, Medicine and Health, The University of Manchester AV Hill Building Manchester M13 9PT UK
- National Graphene Institute, The University of Manchester Booth Street East Manchester M13 9PL UK
| | - Katie Barr
- Nanomedicine Lab, Faculty of Biology, Medicine and Health, The University of Manchester AV Hill Building Manchester M13 9PT UK
- National Graphene Institute, The University of Manchester Booth Street East Manchester M13 9PL UK
| | - Vinicio Rosano
- Nanomedicine Lab, Faculty of Biology, Medicine and Health, The University of Manchester AV Hill Building Manchester M13 9PT UK
- National Graphene Institute, The University of Manchester Booth Street East Manchester M13 9PL UK
| | - Adrián Esteban Arranz
- Nanomedicine Lab, Faculty of Biology, Medicine and Health, The University of Manchester AV Hill Building Manchester M13 9PT UK
- National Graphene Institute, The University of Manchester Booth Street East Manchester M13 9PL UK
| | - Thomas Loret
- Nanomedicine Lab, Faculty of Biology, Medicine and Health, The University of Manchester AV Hill Building Manchester M13 9PT UK
- National Graphene Institute, The University of Manchester Booth Street East Manchester M13 9PL UK
| | - David Spiller
- FBMH Platform Sciences, Enabling Technologies & Infrastructure, FBMH Research & Innovation, Faculty of Biology, Medicine and Health, The University of Manchester Michael Smith Building Manchester M13 9PT UK
| | - Cyrill Bussy
- Nanomedicine Lab, Faculty of Biology, Medicine and Health, The University of Manchester AV Hill Building Manchester M13 9PT UK
- National Graphene Institute, The University of Manchester Booth Street East Manchester M13 9PL UK
| | - Kostas Kostarelos
- Nanomedicine Lab, Faculty of Biology, Medicine and Health, The University of Manchester AV Hill Building Manchester M13 9PT UK
- National Graphene Institute, The University of Manchester Booth Street East Manchester M13 9PL UK
| | - Sandra Vranic
- Nanomedicine Lab, Faculty of Biology, Medicine and Health, The University of Manchester AV Hill Building Manchester M13 9PT UK
- National Graphene Institute, The University of Manchester Booth Street East Manchester M13 9PL UK
| |
Collapse
|
31
|
Musto M, Parisse P, Pachetti M, Memo C, Di Mauro G, Ballesteros B, Lozano N, Kostarelos K, Casalis L, Ballerini L. Corrigendum to Shedding plasma membrane vesicles induced by graphene oxide nanoflakes in brain cultured astrocytes [CARBON 176 (2021) 458–469]. Carbon 2021. [DOI: 10.1016/j.carbon.2021.04.026] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
32
|
Unal MA, Bayrakdar F, Nazir H, Besbinar O, Gurcan C, Lozano N, Arellano LM, Yalcin S, Panatli O, Celik D, Alkaya D, Agan A, Fusco L, Suzuk Yildiz S, Delogu LG, Akcali KC, Kostarelos K, Yilmazer A. Graphene Oxide Nanosheets Interact and Interfere with SARS-CoV-2 Surface Proteins and Cell Receptors to Inhibit Infectivity. Small 2021; 17:e2101483. [PMID: 33988903 PMCID: PMC8236978 DOI: 10.1002/smll.202101483] [Citation(s) in RCA: 38] [Impact Index Per Article: 12.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/13/2021] [Indexed: 05/19/2023]
Abstract
Nanotechnology can offer a number of options against coronavirus disease 2019 (COVID-19) acting both extracellularly and intracellularly to the host cells. Here, the aim is to explore graphene oxide (GO), the most studied 2D nanomaterial in biomedical applications, as a nanoscale platform for interaction with SARS-CoV-2. Molecular docking analyses of GO sheets on interaction with three different structures: SARS-CoV-2 viral spike (open state - 6VYB or closed state - 6VXX), ACE2 (1R42), and the ACE2-bound spike complex (6M0J) are performed. GO shows high affinity for the surface of all three structures (6M0J, 6VYB and 6VXX). When binding affinities and involved bonding types are compared, GO interacts more strongly with the spike or ACE2, compared to 6M0J. Infection experiments using infectious viral particles from four different clades as classified by Global Initiative on Sharing all Influenza Data (GISAID), are performed for validation purposes. Thin, biological-grade GO nanoscale (few hundred nanometers in lateral dimension) sheets are able to significantly reduce copies for three different viral clades. This data has demonstrated that GO sheets have the capacity to interact with SARS-CoV-2 surface components and disrupt infectivity even in the presence of any mutations on the viral spike. GO nanosheets are proposed to be further explored as a nanoscale platform for development of antiviral strategies against COVID-19.
Collapse
Affiliation(s)
| | - Fatma Bayrakdar
- Ministry of Health General Directorate of Public HealthMicrobiology References LaboratorySihhiyeAnkara06430Turkey
| | - Hasan Nazir
- Department of ChemistryAnkara UniversityTandoganAnkara06100Turkey
| | - Omur Besbinar
- Stem Cell InstituteAnkara UniversityBalgatAnkara06520Turkey
- Department of Biomedical EngineeringAnkara UniversityGolbasiAnkara06830Turkey
| | - Cansu Gurcan
- Stem Cell InstituteAnkara UniversityBalgatAnkara06520Turkey
- Department of Biomedical EngineeringAnkara UniversityGolbasiAnkara06830Turkey
| | - Neus Lozano
- Catalan Institute of Nanoscience and Nanotechnology (ICN2)UAB Campus BellaterraBarcelona08193Spain
| | - Luis M. Arellano
- Catalan Institute of Nanoscience and Nanotechnology (ICN2)UAB Campus BellaterraBarcelona08193Spain
| | - Süleyman Yalcin
- Ministry of Health General Directorate of Public HealthMicrobiology References LaboratorySihhiyeAnkara06430Turkey
| | - Oguzhan Panatli
- Department of Biomedical EngineeringAnkara UniversityGolbasiAnkara06830Turkey
| | - Dogantan Celik
- Stem Cell InstituteAnkara UniversityBalgatAnkara06520Turkey
- Department of Biomedical EngineeringAnkara UniversityGolbasiAnkara06830Turkey
| | - Damla Alkaya
- Stem Cell InstituteAnkara UniversityBalgatAnkara06520Turkey
- Department of Biomedical EngineeringAnkara UniversityGolbasiAnkara06830Turkey
| | - Aydan Agan
- Department of Biomedical EngineeringAnkara UniversityGolbasiAnkara06830Turkey
| | - Laura Fusco
- Department of Biomedical SciencesUniversity of PaduaPadua35122Italy
| | - Serap Suzuk Yildiz
- Ministry of Health General Directorate of Public HealthMicrobiology References LaboratorySihhiyeAnkara06430Turkey
| | | | - Kamil Can Akcali
- Stem Cell InstituteAnkara UniversityBalgatAnkara06520Turkey
- Department of BiophysicsFaculty of MedicineAnkara UniversitySihhiyeAnkara06230Turkey
| | - Kostas Kostarelos
- Catalan Institute of Nanoscience and Nanotechnology (ICN2)UAB Campus BellaterraBarcelona08193Spain
- Nanomedicine Lab National Graphene Institute and Faculty of Biology Medicine & HealthThe University of ManchesterAV Hill BuildingManchesterM13 9PTUnited Kingdom
| | - Açelya Yilmazer
- Stem Cell InstituteAnkara UniversityBalgatAnkara06520Turkey
- Department of Biomedical EngineeringAnkara UniversityGolbasiAnkara06830Turkey
| |
Collapse
|
33
|
Kisby T, de Lázaro I, Stylianou M, Cossu G, Kostarelos K. Transient reprogramming of postnatal cardiomyocytes to a dedifferentiated state. PLoS One 2021; 16:e0251054. [PMID: 33951105 PMCID: PMC8099115 DOI: 10.1371/journal.pone.0251054] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/07/2021] [Accepted: 04/19/2021] [Indexed: 11/25/2022] Open
Abstract
In contrast to mammals, lower vertebrates are capable of extraordinary myocardial regeneration thanks to the ability of their cardiomyocytes to undergo transient dedifferentiation and proliferation. Somatic cells can be temporarily reprogrammed to a proliferative, dedifferentiated state through forced expression of Oct3/4, Sox2, Klf4 and c-Myc (OSKM). Here, we aimed to induce transient reprogramming of mammalian cardiomyocytes in vitro utilising an OSKM-encoding non-integrating vector. Reprogramming factor expression in postnatal rat and mouse cardiomyocytes triggered rapid but limited cell dedifferentiation. Concomitantly, a significant increase in cell viability, cell cycle related gene expression and Ki67 positive cells was observed consistent with an enhanced cell cycle activation. The transient nature of this partial reprogramming was confirmed as cardiomyocyte-specific cell morphology, gene expression and contractile activity were spontaneously recovered by day 15 after viral transduction. This study provides the first evidence that adenoviral OSKM delivery can induce partial reprogramming of postnatal cardiomyocytes. Therefore, adenoviral mediated transient reprogramming could be a novel and feasible strategy to recapitulate the regenerative mechanisms of lower vertebrates.
Collapse
Affiliation(s)
- Thomas Kisby
- Nanomedicine Lab, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, United Kingdom
| | - Irene de Lázaro
- Nanomedicine Lab, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, United Kingdom
| | - Maria Stylianou
- Nanomedicine Lab, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, United Kingdom
| | - Giulio Cossu
- Division of Cell Matrix Biology and Regenerative Medicine, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, United Kingdom
| | - Kostas Kostarelos
- Nanomedicine Lab, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, United Kingdom
- Catalan Institute of Nanoscience and Nanotechnology (ICN2), UAB Campus Bellaterra, Barcelona, Spain
| |
Collapse
|
34
|
Musto M, Parisse P, Pachetti M, Memo C, Di Mauro G, Ballesteros B, Lozano N, Kostarelos K, Casalis L, Ballerini L. Shedding plasma membrane vesicles induced by graphene oxide nanoflakes in brain cultured astrocytes. Carbon 2021. [DOI: 10.1016/j.carbon.2021.01.142] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
35
|
Garcia-Cortadella R, Schwesig G, Jeschke C, Illa X, Gray AL, Savage S, Stamatidou E, Schiessl I, Masvidal-Codina E, Kostarelos K, Guimerà-Brunet A, Sirota A, Garrido JA. Author Correction: Graphene active sensor arrays for long-term and wireless mapping of wide frequency band epicortical brain activity. Nat Commun 2021; 12:2568. [PMID: 33931663 PMCID: PMC8087696 DOI: 10.1038/s41467-021-23078-z] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022] Open
Affiliation(s)
- R Garcia-Cortadella
- Catalan Institute of Nanoscience and Nanotechnology (ICN2), CSIC and BIST, Campus UAB, Bellaterra, 08193, Barcelona, Spain
| | - G Schwesig
- Bernstein Center for Computational Neuroscience Munich, Faculty of Medicine, Ludwig-Maximilians Universität München, Planegg-Martinsried, Germany
| | - C Jeschke
- Multi Channel Systems (MCS) GmbH, Reutlingen, Germany
| | - X Illa
- Instituto de Microelectrónica de Barcelona, IMB-CNM (CSIC), Esfera UAB, Bellaterra, Spain.,Centro de Investigación Biomédica en Red en Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Madrid, Spain
| | - Anna L Gray
- Nanomedicine Lab, National Graphene Institute and Faculty of Biology, Medicine & Health, University of Manchester, Manchester, UK
| | - S Savage
- Nanomedicine Lab, National Graphene Institute and Faculty of Biology, Medicine & Health, University of Manchester, Manchester, UK
| | - E Stamatidou
- Nanomedicine Lab, National Graphene Institute and Faculty of Biology, Medicine & Health, University of Manchester, Manchester, UK
| | - I Schiessl
- Division of Neuroscience and Experimental Psychology, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, M13 9PT, UK
| | - E Masvidal-Codina
- Instituto de Microelectrónica de Barcelona, IMB-CNM (CSIC), Esfera UAB, Bellaterra, Spain.,Centro de Investigación Biomédica en Red en Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Madrid, Spain
| | - K Kostarelos
- Catalan Institute of Nanoscience and Nanotechnology (ICN2), CSIC and BIST, Campus UAB, Bellaterra, 08193, Barcelona, Spain.,Nanomedicine Lab, National Graphene Institute and Faculty of Biology, Medicine & Health, University of Manchester, Manchester, UK
| | - A Guimerà-Brunet
- Instituto de Microelectrónica de Barcelona, IMB-CNM (CSIC), Esfera UAB, Bellaterra, Spain.,Centro de Investigación Biomédica en Red en Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Madrid, Spain
| | - A Sirota
- Bernstein Center for Computational Neuroscience Munich, Faculty of Medicine, Ludwig-Maximilians Universität München, Planegg-Martinsried, Germany.
| | - J A Garrido
- Catalan Institute of Nanoscience and Nanotechnology (ICN2), CSIC and BIST, Campus UAB, Bellaterra, 08193, Barcelona, Spain. .,ICREA, Pg. Lluís Companys 23, 08010, Barcelona, Spain.
| |
Collapse
|
36
|
Hadjidemetriou M, Rivers-Auty J, Papafilippou L, Eales J, Kellett KAB, Hooper NM, Lawrence CB, Kostarelos K. Nanoparticle-Enabled Enrichment of Longitudinal Blood Proteomic Fingerprints in Alzheimer's Disease. ACS Nano 2021; 15:7357-7369. [PMID: 33730479 PMCID: PMC8155389 DOI: 10.1021/acsnano.1c00658] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/04/2023]
Abstract
Blood-circulating biomarkers have the potential to detect Alzheimer's disease (AD) pathology before clinical symptoms emerge and to improve the outcomes of clinical trials for disease-modifying therapies. Despite recent advances in understanding concomitant systemic abnormalities, there are currently no validated or clinically used blood-based biomarkers for AD. The extremely low concentration of neurodegeneration-associated proteins in blood necessitates the development of analytical platforms to address the "signal-to-noise" issue and to allow an in-depth analysis of the plasma proteome. Here, we aimed to discover and longitudinally track alterations of the blood proteome in a transgenic mouse model of AD, using a nanoparticle-based proteomics enrichment approach. We employed blood-circulating, lipid-based nanoparticles to extract, analyze and monitor AD-specific protein signatures and to systemically uncover molecular pathways associated with AD progression. Our data revealed the existence of multiple proteomic signals in blood, indicative of the asymptomatic stages of AD. Comprehensive analysis of the nanoparticle-recovered blood proteome by label-free liquid chromatography-tandem mass spectrometry resulted in the discovery of AD-monitoring signatures that could discriminate the asymptomatic phase from amyloidopathy and cognitive deterioration. While the majority of differentially abundant plasma proteins were found to be upregulated at the initial asymptomatic stages, the abundance of these molecules was significantly reduced as a result of amyloidosis, suggesting a disease-stage-dependent fluctuation of the AD-specific blood proteome. The potential use of the proposed nano-omics approach to uncover information in the blood that is directly associated with brain neurodegeneration was further exemplified by the recovery of focal adhesion cascade proteins. We herein propose the integration of nanotechnology with already existing proteomic analytical tools in order to enrich the identification of blood-circulating signals of neurodegeneration, reinvigorating the potential clinical utility of the blood proteome at predicting the onset and kinetics of the AD progression trajectory.
Collapse
Affiliation(s)
- Marilena Hadjidemetriou
- Nanomedicine
Lab, School of Health Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester M13 9PT, United Kingdom
- (M.H.)
| | - Jack Rivers-Auty
- Division
of Neuroscience and Experimental Psychology, School of Biological
Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester Academic Health Science
Centre, Manchester M13 9PT, United Kingdom
| | - Lana Papafilippou
- Nanomedicine
Lab, School of Health Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester M13 9PT, United Kingdom
| | - James Eales
- Division
of Cardiovascular Sciences, School of Medical Sciences, Faculty of
Biology, Medicine and Health, The University
of Manchester M13 9PT, Manchester, United Kingdom
| | - Katherine A. B. Kellett
- Division
of Neuroscience and Experimental Psychology, School of Biological
Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester Academic Health Science
Centre, Manchester M13 9PT, United Kingdom
| | - Nigel M. Hooper
- Division
of Neuroscience and Experimental Psychology, School of Biological
Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester Academic Health Science
Centre, Manchester M13 9PT, United Kingdom
| | - Catherine B. Lawrence
- Division
of Neuroscience and Experimental Psychology, School of Biological
Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester Academic Health Science
Centre, Manchester M13 9PT, United Kingdom
| | - Kostas Kostarelos
- Nanomedicine
Lab, School of Health Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester M13 9PT, United Kingdom
- (K.K.)
| |
Collapse
|
37
|
Shin Y, Just-Baringo X, Boyes M, Panigrahi A, Zarattini M, Chen Y, Liu X, Morris G, Prestat E, Kostarelos K, Vranic S, Larrosa I, Casiraghi C. Enhanced liquid phase exfoliation of graphene in water using an insoluble bis-pyrene stabiliser. Faraday Discuss 2021; 227:46-60. [PMID: 33295354 DOI: 10.1039/c9fd00114j] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
Abstract
Stabilisers, such as surfactants, polymers and polyaromatic molecules, offer an effective way to produce graphene dispersions in water by Liquid Phase Exfoliation (LPE) without degrading the properties of graphene. In particular, pyrene derivatives provide better exfoliation efficiency than traditional surfactants and polymers. A stabiliser is expected to be relatively soluble in order to disperse hydrophobic graphene in water. Here, we show that exfoliation can also be achieved with insoluble pyrene stabilisers if appropriately designed. In particular, bis-pyrene stabilisers (BPSs) functionalised with pyrrolidine provide a higher exfoliation efficiency and percentage of single layers compared to traditional pyrene derivatives under the same experimental conditions. This is attributed to the enhanced interactions between BPS and graphene, provided by the presence of two pyrene binding groups. This approach is therefore attractive not only to produce highly concentrated graphene, but also to use graphene to disperse insoluble molecules in water. The enhanced adsorption of BPS on graphene, however, is reflected in higher toxicity towards human epithelial bronchial immortalized cells, limiting the use of this material for biomedical applications.
Collapse
Affiliation(s)
- Yuyoung Shin
- Department of Chemistry, University of Manchester, Oxford Road, Manchester, M13 9PL, UK.
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
38
|
Backes C, Behera RK, Bianco A, Casiraghi C, Doan H, Criado A, Galembeck F, Goldie S, Gravagnuolo AM, Hou HL, Kamali AR, Kostarelos K, Kumar V, Lee WH, Martsinovich N, Palermo V, Palma M, Pang J, Prato M, Samori P, Silvestri A, Singh S, Strano M, Wetzl C. Biomedical applications: general discussion. Faraday Discuss 2021; 227:245-258. [PMID: 33877208 DOI: 10.1039/d1fd90003j] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
|
39
|
Franceschi Biagioni A, Cellot G, Pati E, Lozano N, Ballesteros B, Casani R, Coimbra NC, Kostarelos K, Ballerini L. Graphene oxide prevents lateral amygdala dysfunctional synaptic plasticity and reverts long lasting anxiety behavior in rats. Biomaterials 2021; 271:120749. [PMID: 33714913 DOI: 10.1016/j.biomaterials.2021.120749] [Citation(s) in RCA: 14] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/30/2020] [Revised: 02/23/2021] [Accepted: 02/27/2021] [Indexed: 12/19/2022]
Abstract
Engineered small graphene oxide (s-GO) sheets were previously shown to reversibly down-regulate glutamatergic synapses in the hippocampus of juvenile rats, disclosing an unexpected translational potential of these nanomaterials to target selective synapses in vivo. Synapses are anatomical specializations acting in the Central Nervous System (CNS) as functional interfaces among neurons. Dynamic changes in synaptic function, named synaptic plasticity, are crucial to learning and memory. More recently, pathological mechanisms involving dysfunctional synaptic plasticity were implicated in several brain diseases, from dementia to anxiety disorders. Hyper-excitability of glutamatergic neurons in the lateral nucleus of the amygdala complex (LA) is substantially involved in the storage of aversive memory induced by stressful events enabling post-traumatic stress disorder (PTSD). Here we translated in PTSD animal model the ability of s-GO, when stereotaxically administered to hamper LA glutamatergic transmission and to prevent the behavioral response featured in long-term aversive memory. We propose that s-GO, by interference with glutamatergic plasticity, impair LA-dependent memory retrieval related to PTSD.
Collapse
Affiliation(s)
- Audrey Franceschi Biagioni
- Neuron Physiology and Technology Lab, International School for Advanced Studies (SISSA), Neuroscience, Via Bonomea 265, 34136, Trieste, Italy
| | - Giada Cellot
- Neuron Physiology and Technology Lab, International School for Advanced Studies (SISSA), Neuroscience, Via Bonomea 265, 34136, Trieste, Italy
| | - Elisa Pati
- Neuron Physiology and Technology Lab, International School for Advanced Studies (SISSA), Neuroscience, Via Bonomea 265, 34136, Trieste, Italy
| | - Neus Lozano
- Catalan Institute of Nanoscience and Nanotechnology (ICN2), CSIC and BIST, Campus UAB, Bellaterra, 08193, Barcelona, Spain
| | - Belén Ballesteros
- Catalan Institute of Nanoscience and Nanotechnology (ICN2), CSIC and BIST, Campus UAB, Bellaterra, 08193, Barcelona, Spain
| | - Raffaele Casani
- Neuron Physiology and Technology Lab, International School for Advanced Studies (SISSA), Neuroscience, Via Bonomea 265, 34136, Trieste, Italy
| | - Norberto Cysne Coimbra
- Laboratory of Neuroanatomy & Neuropsychobiology, Department of Pharmacology, Ribeirão Preto Medical School of the University of São Paulo (FMRP-USP), Av. Bandeirantes 3900, 14049-900, Ribeirão Preto, SP, Brazil
| | - Kostas Kostarelos
- Catalan Institute of Nanoscience and Nanotechnology (ICN2), CSIC and BIST, Campus UAB, Bellaterra, 08193, Barcelona, Spain; Nanomedicine Lab, National Graphene Institute and Faculty of Biology, Medicine & Health, The University of Manchester, AV Hill Building, Oxford Rd, Manchester, M13 9PL, United Kingdom
| | - Laura Ballerini
- Neuron Physiology and Technology Lab, International School for Advanced Studies (SISSA), Neuroscience, Via Bonomea 265, 34136, Trieste, Italy.
| |
Collapse
|
40
|
Garcia-Cortadella R, Schwesig G, Jeschke C, Illa X, Gray AL, Savage S, Stamatidou E, Schiessl I, Masvidal-Codina E, Kostarelos K, Guimerà-Brunet A, Sirota A, Garrido JA. Graphene active sensor arrays for long-term and wireless mapping of wide frequency band epicortical brain activity. Nat Commun 2021; 12:211. [PMID: 33431878 PMCID: PMC7801381 DOI: 10.1038/s41467-020-20546-w] [Citation(s) in RCA: 28] [Impact Index Per Article: 9.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/22/2020] [Accepted: 12/08/2020] [Indexed: 01/29/2023] Open
Abstract
Graphene active sensors have demonstrated promising capabilities for the detection of electrophysiological signals in the brain. Their functional properties, together with their flexibility as well as their expected stability and biocompatibility have raised them as a promising building block for large-scale sensing neural interfaces. However, in order to provide reliable tools for neuroscience and biomedical engineering applications, the maturity of this technology must be thoroughly studied. Here, we evaluate the performance of 64-channel graphene sensor arrays in terms of homogeneity, sensitivity and stability using a wireless, quasi-commercial headstage and demonstrate the biocompatibility of epicortical graphene chronic implants. Furthermore, to illustrate the potential of the technology to detect cortical signals from infra-slow to high-gamma frequency bands, we perform proof-of-concept long-term wireless recording in a freely behaving rodent. Our work demonstrates the maturity of the graphene-based technology, which represents a promising candidate for chronic, wide frequency band neural sensing interfaces.
Collapse
Affiliation(s)
- R Garcia-Cortadella
- Catalan Institute of Nanoscience and Nanotechnology (ICN2), CSIC and BIST, Campus UAB, Bellaterra, 08193, Barcelona, Spain
| | - G Schwesig
- Bernstein Center for Computational Neuroscience Munich, Faculty of Medicine, Ludwig-Maximilians Universität München, Planegg-Martinsried, Germany
| | - C Jeschke
- Multi Channel Systems (MCS) GmbH, Reutlingen, Germany
| | - X Illa
- Instituto de Microelectrónica de Barcelona, IMB-CNM (CSIC), Esfera UAB, Bellaterra, Spain
- Centro de Investigación Biomédica en Red en Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Madrid, Spain
| | - Anna L Gray
- Nanomedicine Lab, National Graphene Institute and Faculty of Biology, Medicine & Health, University of Manchester, Manchester, UK
| | - S Savage
- Nanomedicine Lab, National Graphene Institute and Faculty of Biology, Medicine & Health, University of Manchester, Manchester, UK
| | - E Stamatidou
- Nanomedicine Lab, National Graphene Institute and Faculty of Biology, Medicine & Health, University of Manchester, Manchester, UK
| | - I Schiessl
- Division of Neuroscience and Experimental Psychology, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, M13 9PT, UK
| | - E Masvidal-Codina
- Instituto de Microelectrónica de Barcelona, IMB-CNM (CSIC), Esfera UAB, Bellaterra, Spain
- Centro de Investigación Biomédica en Red en Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Madrid, Spain
| | - K Kostarelos
- Catalan Institute of Nanoscience and Nanotechnology (ICN2), CSIC and BIST, Campus UAB, Bellaterra, 08193, Barcelona, Spain
- Nanomedicine Lab, National Graphene Institute and Faculty of Biology, Medicine & Health, University of Manchester, Manchester, UK
| | - A Guimerà-Brunet
- Instituto de Microelectrónica de Barcelona, IMB-CNM (CSIC), Esfera UAB, Bellaterra, Spain
- Centro de Investigación Biomédica en Red en Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Madrid, Spain
| | - A Sirota
- Bernstein Center for Computational Neuroscience Munich, Faculty of Medicine, Ludwig-Maximilians Universität München, Planegg-Martinsried, Germany.
| | - J A Garrido
- Catalan Institute of Nanoscience and Nanotechnology (ICN2), CSIC and BIST, Campus UAB, Bellaterra, 08193, Barcelona, Spain.
- ICREA, Pg. Lluís Companys 23, 08010, Barcelona, Spain.
| |
Collapse
|
41
|
Yan X, Zhou Q, Vincent M, Deng Y, Yu J, Xu J, Xu T, Tang T, Bian L, Wang YXJ, Kostarelos K, Zhang L. Multifunctional biohybrid magnetite microrobots for imaging-guided therapy. Sci Robot 2021; 2:2/12/eaaq1155. [PMID: 33157904 DOI: 10.1126/scirobotics.aaq1155] [Citation(s) in RCA: 331] [Impact Index Per Article: 110.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/24/2017] [Revised: 10/04/2017] [Accepted: 11/03/2017] [Indexed: 12/14/2022]
Abstract
Magnetic microrobots and nanorobots can be remotely controlled to propel in complex biological fluids with high precision by using magnetic fields. Their potential for controlled navigation in hard-to-reach cavities of the human body makes them promising miniaturized robotic tools to diagnose and treat diseases in a minimally invasive manner. However, critical issues, such as motion tracking, biocompatibility, biodegradation, and diagnostic/therapeutic effects, need to be resolved to allow preclinical in vivo development and clinical trials. We report biohybrid magnetic robots endowed with multifunctional capabilities by integrating desired structural and functional attributes from a biological matrix and an engineered coating. Helical microswimmers were fabricated from Spirulina microalgae via a facile dip-coating process in magnetite (Fe3O4) suspensions, superparamagnetic, and equipped with robust navigation capability in various biofluids. The innate properties of the microalgae allowed in vivo fluorescence imaging and remote diagnostic sensing without the need for any surface modification. Furthermore, in vivo magnetic resonance imaging tracked a swarm of microswimmers inside rodent stomachs, a deep organ where fluorescence-based imaging ceased to work because of its penetration limitation. Meanwhile, the microswimmers were able to degrade and exhibited selective cytotoxicity to cancer cell lines, subject to the thickness of the Fe3O4 coating, which could be tailored via the dip-coating process. The biohybrid microrobots reported herein represent a microrobotic platform that could be further developed for in vivo imaging-guided therapy and a proof of concept for the engineering of multifunctional microrobotic and nanorobotic devices.
Collapse
Affiliation(s)
- Xiaohui Yan
- Department of Mechanical and Automation Engineering, Chinese University of Hong Kong, Shatin, New Territories, Hong Kong SAR, China
| | - Qi Zhou
- School of Engineering, University of Edinburgh, Edinburgh EH9 3FB, UK
| | - Melissa Vincent
- Nanomedicine Laboratory, Faculty of Biology, Medicine and Health, University of Manchester, AV Hill Building, Manchester M13 9PT, UK
| | - Yan Deng
- Department of Obstetrics and Gynaecology, Chinese University of Hong Kong, Shatin, New Territories, Hong Kong SAR, China
| | - Jiangfan Yu
- Department of Mechanical and Automation Engineering, Chinese University of Hong Kong, Shatin, New Territories, Hong Kong SAR, China
| | - Jianbin Xu
- Department of Biomedical Engineering, Chinese University of Hong Kong, Shatin, New Territories, Hong Kong SAR, China
| | - Tiantian Xu
- Department of Mechanical and Automation Engineering, Chinese University of Hong Kong, Shatin, New Territories, Hong Kong SAR, China
| | - Tao Tang
- Department of Obstetrics and Gynaecology, Chinese University of Hong Kong, Shatin, New Territories, Hong Kong SAR, China
| | - Liming Bian
- Department of Mechanical and Automation Engineering, Chinese University of Hong Kong, Shatin, New Territories, Hong Kong SAR, China.,Department of Biomedical Engineering, Chinese University of Hong Kong, Shatin, New Territories, Hong Kong SAR, China
| | - Yi-Xiang J Wang
- Department of Imaging and Interventional Radiology, Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong SAR, China
| | - Kostas Kostarelos
- Nanomedicine Laboratory, Faculty of Biology, Medicine and Health, University of Manchester, AV Hill Building, Manchester M13 9PT, UK
| | - Li Zhang
- Department of Mechanical and Automation Engineering, Chinese University of Hong Kong, Shatin, New Territories, Hong Kong SAR, China.
| |
Collapse
|
42
|
Papafilippou L, Claxton A, Dark P, Kostarelos K, Hadjidemetriou M. Nanotools for Sepsis Diagnosis and Treatment. Adv Healthc Mater 2021; 10:e2001378. [PMID: 33236524 DOI: 10.1002/adhm.202001378] [Citation(s) in RCA: 48] [Impact Index Per Article: 16.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/05/2020] [Revised: 10/07/2020] [Indexed: 12/12/2022]
Abstract
Sepsis is one of the leading causes of death worldwide with high mortality rates and a pathological complexity hindering early and accurate diagnosis. Today, laboratory culture tests are the epitome of pathogen recognition in sepsis. However, their consistency remains an issue of controversy with false negative results often observed. Clinically used blood markers, C reactive protein (CRP) and procalcitonin (PCT) are indicators of an acute-phase response and thus lack specificity, offering limited diagnostic efficacy. In addition to poor diagnosis, inefficient drug delivery and the increasing prevalence of antibiotic-resistant microorganisms constitute significant barriers in antibiotic stewardship and impede effective therapy. These challenges have prompted the exploration for alternative strategies that pursue accurate diagnosis and effective treatment. Nanomaterials are examined for both diagnostic and therapeutic purposes in sepsis. The nanoparticle (NP)-enabled capture of sepsis causative agents and/or sepsis biomarkers in biofluids can revolutionize sepsis diagnosis. From the therapeutic point of view, currently existing nanoscale drug delivery systems have proven to be excellent allies in targeted therapy, while many other nanotherapeutic applications are envisioned. Herein, the most relevant applications of nanomedicine for the diagnosis, prognosis, and treatment of sepsis is reviewed, providing a critical assessment of their potentiality for clinical translation.
Collapse
Affiliation(s)
- Lana Papafilippou
- Nanomedicine Lab Faculty of Biology Medicine and Health AV Hill Building The University of Manchester Manchester M13 9PT UK
| | - Andrew Claxton
- Department of Critical Care Salford Royal Foundation Trust Stott Lane Salford M6 8HD UK
| | - Paul Dark
- Manchester NIHR Biomedical Research Centre Division of Infection Immunity and Respiratory Medicine University of Manchester Manchester M13 9PT UK
| | - Kostas Kostarelos
- Nanomedicine Lab Faculty of Biology Medicine and Health AV Hill Building The University of Manchester Manchester M13 9PT UK
- Catalan Institute of Nanoscience and Nanotechnology (ICN2) Campus UAB Bellaterra Barcelona 08193 Spain
| | - Marilena Hadjidemetriou
- Nanomedicine Lab Faculty of Biology Medicine and Health AV Hill Building The University of Manchester Manchester M13 9PT UK
| |
Collapse
|
43
|
Wang B, Kostarelos K, Nelson BJ, Zhang L. Trends in Micro-/Nanorobotics: Materials Development, Actuation, Localization, and System Integration for Biomedical Applications. Adv Mater 2021; 33:e2002047. [PMID: 33617105 DOI: 10.1002/adma.202002047] [Citation(s) in RCA: 162] [Impact Index Per Article: 54.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/24/2020] [Revised: 08/24/2020] [Indexed: 05/23/2023]
Abstract
Micro-/nanorobots (m-bots) have attracted significant interest due to their suitability for applications in biomedical engineering and environmental remediation. Particularly, their applications in in vivo diagnosis and intervention have been the focus of extensive research in recent years with various clinical imaging techniques being applied for localization and tracking. The successful integration of well-designed m-bots with surface functionalization, remote actuation systems, and imaging techniques becomes the crucial step toward biomedical applications, especially for the in vivo uses. This review thus addresses four different aspects of biomedical m-bots: design/fabrication, functionalization, actuation, and localization. The biomedical applications of the m-bots in diagnosis, sensing, microsurgery, targeted drug/cell delivery, thrombus ablation, and wound healing are reviewed from these viewpoints. The developed biomedical m-bot systems are comprehensively compared and evaluated based on their characteristics. The current challenges and the directions of future research in this field are summarized.
Collapse
Affiliation(s)
- Ben Wang
- Department of Mechanical and Automation Engineering, The Chinese University of Hong Kong, Shatin N.T., Hong Kong, China
- College of Chemistry and Environmental Engineering, Shenzhen University, Shenzhen, 518060, China
| | - Kostas Kostarelos
- Nanomedicine Lab, Faculty of Biology, Medicine & Health, The University of Manchester, AV Hill Building, Manchester, M13 9PT, UK
- Catalan Institute of Nanoscience and Nanotechnology (ICN2), Campus UAB, Bellaterra, Barcelona, Spain
| | - Bradley J Nelson
- Institute of Robotics and Intelligent Systems (IRIS), ETH Zurich, Tannenstrasse 3, Zurich, CH-8092, Switzerland
| | - Li Zhang
- Department of Mechanical and Automation Engineering, The Chinese University of Hong Kong, Shatin N.T., Hong Kong, China
- CUHK T Stone Robotics Institute, The Chinese University of Hong Kong, Shatin N.T., Hong Kong, China
| |
Collapse
|
44
|
Portioli C, Bussy C, Mazza M, Lozano N, Jasim DA, Prato M, Bianco A, Bentivoglio M, Kostarelos K. Intracerebral Injection of Graphene Oxide Nanosheets Mitigates Microglial Activation Without Inducing Acute Neurotoxicity: A Pilot Comparison to Other Nanomaterials. Small 2020; 16:e2004029. [PMID: 33210448 DOI: 10.1002/smll.202004029] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/03/2020] [Revised: 10/09/2020] [Indexed: 05/24/2023]
Abstract
Carbon-based nanomaterials (CNMs) are being explored for neurological applications. However, systematic in vivo studies investigating the effects of CNM nanocarriers in the brain and how brain cells respond to such nanomaterials are scarce. To address this, functionalized multiwalled carbon nanotubes and graphene oxide (GO) sheets are injected in mice brain and compared with charged liposomes. The induction of acute neuroinflammatory and neurotoxic effects locally and in brain structures distant from the injection site are assessed up to 1 week postadministration. While significant neuronal cell loss and sustained microglial cell activation are observed after injection of cationic liposomes, none of the tested CNMs induces either neurodegeneration or microglial activation. Among the candidate nanocarriers tested, GO sheets appear to elicit the least deleterious neuroinflammatory profile. At molecular level, GO induces moderate activation of proinflammatory markers compared to vehicle control. At histological level, brain response to GO is lower than after vehicle control injection, suggesting some capacity for GO to reduce the impact of stereotactic injection on brain. While these findings are encouraging and valuable in the selection and design of nanomaterial-based brain delivery systems, they warrant further investigations to better understand the mechanisms underlying GO immunomodulatory properties in brain.
Collapse
Affiliation(s)
- Corinne Portioli
- Nanomedicine Lab, School of Health Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, M13 9PL, UK
- Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, 37134, Italy
| | - Cyrill Bussy
- Nanomedicine Lab, School of Health Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, M13 9PL, UK
- National Graphene Institute, The University of Manchester, Manchester, M13 9PL, UK
- Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, M13 9PL, UK
| | - Mariarosa Mazza
- Nanomedicine Lab, School of Health Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, M13 9PL, UK
| | - Neus Lozano
- Nanomedicine Lab, School of Health Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, M13 9PL, UK
- National Graphene Institute, The University of Manchester, Manchester, M13 9PL, UK
- Catalan Institute of Nanoscience and Nanotechnology (ICN2) and The Barcelona Institute of Science and Technology (BIST), Campus UAB, Bellaterra, Barcelona, 08193, Spain
| | - Dhifaf A Jasim
- Nanomedicine Lab, School of Health Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, M13 9PL, UK
- National Graphene Institute, The University of Manchester, Manchester, M13 9PL, UK
| | - Maurizio Prato
- Department of Chemical and Pharmaceutical Sciences, University of Trieste, Trieste, 34127, Italy
- Center for Cooperative Research in Biomaterials (CIC biomaGUNE), Basque Research and Technology Alliance (BRTA), Paseo de Miramón 182, Donostia-San Sebastián, 20014, Spain
- Ikerbasque, Basque Foundation for Science, Bilbao, 48009, Spain
| | - Alberto Bianco
- CNRS, Immunology, Immunopathology and Therapeutic Chemistry, UPR3572, ISIS, University of Strasbourg, Strasbourg, 67000, France
| | - Marina Bentivoglio
- Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, 37134, Italy
| | - Kostas Kostarelos
- Nanomedicine Lab, School of Health Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, M13 9PL, UK
- National Graphene Institute, The University of Manchester, Manchester, M13 9PL, UK
- Catalan Institute of Nanoscience and Nanotechnology (ICN2) and The Barcelona Institute of Science and Technology (BIST), Campus UAB, Bellaterra, Barcelona, 08193, Spain
| |
Collapse
|
45
|
Gardner L, Warrington J, Rogan J, Rothwell DG, Brady G, Dive C, Kostarelos K, Hadjidemetriou M. The biomolecule corona of lipid nanoparticles contains circulating cell-free DNA. Nanoscale Horiz 2020; 5:1476-1486. [PMID: 32853302 DOI: 10.1039/d0nh00333f] [Citation(s) in RCA: 14] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/20/2023]
Abstract
The spontaneous adsorption of biomolecules onto the surface of nanoparticles (NPs) in complex physiological biofluids has been widely investigated over the last decade. Characterisation of the protein composition of the 'biomolecule corona' has dominated research efforts, whereas other classes of biomolecules, such as nucleic acids, have received no interest. Scarce, speculative statements exist in the literature about the presence of nucleic acids in the biomolecule corona, with no previous studies attempting to describe the contribution of genomic content to the blood-derived NP corona. Herein, we provide the first experimental evidence of the interaction of circulating cell-free DNA (cfDNA) with lipid-based NPs upon their incubation with human plasma samples, obtained from healthy volunteers and ovarian carcinoma patients. Our results also demonstrate an increased amount of detectable cfDNA in patients with cancer. Proteomic analysis of the same biomolecule coronas revealed the presence of histone proteins, suggesting an indirect, nucleosome-mediated NP-cfDNA interaction. The finding of cfDNA as part of the NP corona, offers a previously unreported new scope regarding the chemical composition of the 'biomolecule corona' and opens up new possibilities for the potential exploitation of the biomolecule corona for the enrichment and analysis of blood-circulating nucleic acids.
Collapse
Affiliation(s)
- Lois Gardner
- Nanomedicine Lab, Faculty of Biology, Medicine and Health, The University of Manchester, AV Hill Building, Manchester, UK.
| | | | | | | | | | | | | | | |
Collapse
|
46
|
Gallud A, Delaval M, Kinaret P, Marwah VS, Fortino V, Ytterberg J, Zubarev R, Skoog T, Kere J, Correia M, Loeschner K, Al‐Ahmady Z, Kostarelos K, Ruiz J, Astruc D, Monopoli M, Handy R, Moya S, Savolainen K, Alenius H, Greco D, Fadeel B. Multiparametric Profiling of Engineered Nanomaterials: Unmasking the Surface Coating Effect. Adv Sci (Weinh) 2020; 7:2002221. [PMID: 33240770 PMCID: PMC7675037 DOI: 10.1002/advs.202002221] [Citation(s) in RCA: 13] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/12/2020] [Revised: 07/29/2020] [Indexed: 05/02/2023]
Abstract
Despite considerable efforts, the properties that drive the cytotoxicity of engineered nanomaterials (ENMs) remain poorly understood. Here, the authors inverstigate a panel of 31 ENMs with different core chemistries and a variety of surface modifications using conventional in vitro assays coupled with omics-based approaches. Cytotoxicity screening and multiplex-based cytokine profiling reveals a good concordance between primary human monocyte-derived macrophages and the human monocyte-like cell line THP-1. Proteomics analysis following a low-dose exposure of cells suggests a nonspecific stress response to ENMs, while microarray-based profiling reveals significant changes in gene expression as a function of both surface modification and core chemistry. Pathway analysis highlights that the ENMs with cationic surfaces that are shown to elicit cytotoxicity downregulated DNA replication and cell cycle responses, while inflammatory responses are upregulated. These findings are validated using cell-based assays. Notably, certain small, PEGylated ENMs are found to be noncytotoxic yet they induce transcriptional responses reminiscent of viruses. In sum, using a multiparametric approach, it is shown that surface chemistry is a key determinant of cellular responses to ENMs. The data also reveal that cytotoxicity, determined by conventional in vitro assays, does not necessarily correlate with transcriptional effects of ENMs.
Collapse
Affiliation(s)
- Audrey Gallud
- Institute of Environmental MedicineKarolinska InstitutetStockholm171 77Sweden
| | - Mathilde Delaval
- Institute of Environmental MedicineKarolinska InstitutetStockholm171 77Sweden
| | - Pia Kinaret
- Faculty of Medicine and Health TechnologyTampere UniversityTampere33720Finland
- Institute of BiotechnologyUniversity of HelsinkiHelsinki00790Finland
| | - Veer Singh Marwah
- Faculty of Medicine and Health TechnologyTampere UniversityTampere33720Finland
- Institute of BiotechnologyUniversity of HelsinkiHelsinki00790Finland
| | - Vittorio Fortino
- Institute of BiomedicineUniversity of Eastern FinlandKuopio70211Finland
| | - Jimmy Ytterberg
- Department of Medical Biochemistry & BiophysicsKarolinska InstitutetStockholm171 77Sweden
| | - Roman Zubarev
- Department of Medical Biochemistry & BiophysicsKarolinska InstitutetStockholm171 77Sweden
| | - Tiina Skoog
- Department of Biosciences & NutritionKarolinska InstitutetHuddinge141 83Sweden
| | - Juha Kere
- Department of Biosciences & NutritionKarolinska InstitutetHuddinge141 83Sweden
| | - Manuel Correia
- National Food InstituteTechnical University of DenmarkKongens Lyngby2800Denmark
| | - Katrin Loeschner
- National Food InstituteTechnical University of DenmarkKongens Lyngby2800Denmark
| | - Zahraa Al‐Ahmady
- Faculty of BiologyMedicine & HealthUniversity of ManchesterManchesterM20 4GJUK
- School of Science & TechnologyNottingham Trent UniversityNottinghamNG1 8NSUK
| | - Kostas Kostarelos
- Faculty of BiologyMedicine & HealthUniversity of ManchesterManchesterM20 4GJUK
- Catalan Institute of Nanoscience and Nanotechnology (ICN2)Barcelona08193Spain
| | - Jaime Ruiz
- ISMUMR CNRS No. 5255University of BordeauxTalence33 405France
| | - Didier Astruc
- ISMUMR CNRS No. 5255University of BordeauxTalence33 405France
| | - Marco Monopoli
- Department of Pharmaceutical & Medicinal ChemistryRoyal College of Surgeons in Ireland (RCSI)Dublin2Ireland
| | - Richard Handy
- School of Biological & Marine SciencesUniversity of PlymouthPlymouthPL4 8AAUK
| | - Sergio Moya
- Soft Matter Nanotechnology LaboratoryCIC biomaGUNEDonostia‐San Sebastián20014Spain
| | - Kai Savolainen
- Finnish Institute of Occupational HealthHelsinki00032Finland
| | - Harri Alenius
- Institute of Environmental MedicineKarolinska InstitutetStockholm171 77Sweden
- Institute of BiotechnologyUniversity of HelsinkiHelsinki00790Finland
| | - Dario Greco
- Faculty of Medicine and Health TechnologyTampere UniversityTampere33720Finland
- Institute of BiotechnologyUniversity of HelsinkiHelsinki00790Finland
| | - Bengt Fadeel
- Institute of Environmental MedicineKarolinska InstitutetStockholm171 77Sweden
| |
Collapse
|
47
|
Kisby T, Lázaro I, Fisch S, Cartwright EJ, Cossu G, Kostarelos K. Adenoviral Mediated Delivery of OSKM Factors Induces Partial Reprogramming of Mouse Cardiac Cells In Vivo. Adv Therap 2020. [DOI: 10.1002/adtp.202000141] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
Affiliation(s)
- Thomas Kisby
- Nanomedicine Lab Faculty of Biology Medicine and Health AV Hill Building The University of Manchester Manchester M13 9PT UK
| | - Irene Lázaro
- Nanomedicine Lab Faculty of Biology Medicine and Health AV Hill Building The University of Manchester Manchester M13 9PT UK
- Harvard John A. Paulson School of Engineering and Applied Sciences 58 Oxford Street Cambridge MA 02138 USA
- Wyss Institute for Biologically Inspired Engineering at Harvard University Center for Life Science 3 Blackfan Circle Boston MA 02115 USA
| | - Sudeshna Fisch
- Cardiovascular Physiology Core Brigham and Women's Hospital Harvard Medical School Boston MA 02115 USA
| | - Elizabeth J. Cartwright
- Division of Cardiovascular Sciences Faculty of Biology Medicine and Health Manchester Academic Health Science Centre The University of Manchester Manchester M13 9PL UK
| | - Giulio Cossu
- Division of Cell Matrix Biology and Regenerative Medicine Faculty of Biology Medicine and Health The University of Manchester Manchester M13 9PT UK
| | - Kostas Kostarelos
- Nanomedicine Lab Faculty of Biology Medicine and Health AV Hill Building The University of Manchester Manchester M13 9PT UK
- Catalan Institute of Nanoscience and Nanotechnology (ICN2) Campus UAB Bellaterra Barcelona 08193 Spain
| |
Collapse
|
48
|
Lázaro I, Sharp P, Gurcan C, Ceylan A, Stylianou M, Kisby T, Chen Y, Vranic S, Barr K, Taheri H, Ozen A, Bussy C, Yilmazer A, Kostarelos K. Deep Tissue Translocation of Graphene Oxide Sheets in Human Glioblastoma 3D Spheroids and an Orthotopic Xenograft Model. Adv Therap 2020. [DOI: 10.1002/adtp.202000109] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Affiliation(s)
- Irene Lázaro
- Nanomedicine Lab, National Graphene Institute and Faculty of Biology, Medicine and Health University of Manchester AV Hill Building Manchester M13 9PT UK
- John A Paulson School of Engineering and Applied Sciences Harvard University 58 Oxford Street Cambridge MA 02138 USA
- Wyss Institute for Biologically Inspired Engineering at Harvard University 3 Blackfan Circle Boston MA 02115 USA
| | - Paul Sharp
- Nanomedicine Lab, National Graphene Institute and Faculty of Biology, Medicine and Health University of Manchester AV Hill Building Manchester M13 9PT UK
| | - Cansu Gurcan
- Department of Biomedical Engineering, Faculty of Engineering Ankara University Ankara 06830 Turkey
- Stem Cell Institute Ankara University Ankara 06520 Turkey
| | - Ahmet Ceylan
- Department of Histology Embryology, Faculty of Veterinary Medicine Ankara University Ankara 06110 Turkey
| | - Maria Stylianou
- Nanomedicine Lab, National Graphene Institute and Faculty of Biology, Medicine and Health University of Manchester AV Hill Building Manchester M13 9PT UK
| | - Thomas Kisby
- Nanomedicine Lab, National Graphene Institute and Faculty of Biology, Medicine and Health University of Manchester AV Hill Building Manchester M13 9PT UK
| | - Yingxian Chen
- Nanomedicine Lab, National Graphene Institute and Faculty of Biology, Medicine and Health University of Manchester AV Hill Building Manchester M13 9PT UK
| | - Sandra Vranic
- Nanomedicine Lab, National Graphene Institute and Faculty of Biology, Medicine and Health University of Manchester AV Hill Building Manchester M13 9PT UK
| | - Katharine Barr
- Nanomedicine Lab, National Graphene Institute and Faculty of Biology, Medicine and Health University of Manchester AV Hill Building Manchester M13 9PT UK
| | - Hadiseh Taheri
- Department of Biomedical Engineering, Faculty of Engineering Ankara University Ankara 06830 Turkey
| | - Asuman Ozen
- Department of Histology Embryology, Faculty of Veterinary Medicine Ankara University Ankara 06110 Turkey
| | - Cyrill Bussy
- Nanomedicine Lab, National Graphene Institute and Faculty of Biology, Medicine and Health University of Manchester AV Hill Building Manchester M13 9PT UK
| | - Acelya Yilmazer
- Department of Biomedical Engineering, Faculty of Engineering Ankara University Ankara 06830 Turkey
- Stem Cell Institute Ankara University Ankara 06520 Turkey
| | - Kostas Kostarelos
- Nanomedicine Lab, National Graphene Institute and Faculty of Biology, Medicine and Health University of Manchester AV Hill Building Manchester M13 9PT UK
- Catalan Institute of Nanoscience and Nanotechnology (ICN2) UAB Campus Bellaterra Barcelona 08193 Spain
| |
Collapse
|
49
|
Newman L, Jasim DA, Prestat E, Lozano N, de Lazaro I, Nam Y, Assas BM, Pennock J, Haigh SJ, Bussy C, Kostarelos K. Splenic Capture and In Vivo Intracellular Biodegradation of Biological-Grade Graphene Oxide Sheets. ACS Nano 2020; 14:10168-10186. [PMID: 32658456 PMCID: PMC7458483 DOI: 10.1021/acsnano.0c03438] [Citation(s) in RCA: 28] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/24/2020] [Accepted: 07/13/2020] [Indexed: 05/20/2023]
Abstract
Carbon nanomaterials, including 2D graphene-based materials, have shown promising applicability to drug delivery, tissue engineering, diagnostics, and various other biomedical areas. However, to exploit the benefits of these materials in some of the areas mentioned, it is necessary to understand their possible toxicological implications and long-term fate in vivo. We previously demonstrated that following intravenous administration, 2D graphene oxide (GO) nanosheets were largely excreted via the kidneys; however, a small but significant portion of the material was sequestered in the spleen. Herein, we interrogate the potential consequences of this accumulation and the fate of the spleen-residing GO over a period of nine months. We show that our thoroughly characterized GO materials are not associated with any detectable pathological consequences in the spleen. Using confocal Raman mapping of tissue sections, we determine the sub-organ biodistribution of GO at various time points after administration. The cells largely responsible for taking up the material are confirmed using immunohistochemistry coupled with Raman spectroscopy, and transmission electron microscopy (TEM). This combination of techniques identified cells of the splenic marginal zone as the main site of GO bioaccumulation. In addition, through analyses using both bright-field TEM coupled with electron diffraction and Raman spectroscopy, we reveal direct evidence of in vivo intracellular biodegradation of GO sheets with ultrastructural precision. This work offers critical information about biological processing and degradation of thin GO sheets by normal mammalian tissue, indicating that further development and exploitation of GO in biomedicine would be possible.
Collapse
Affiliation(s)
- Leon Newman
- Nanomedicine
Lab, National Graphene Institute and Faculty of Biology, Medicine
& Health, The University of Manchester, Manchester, M13 9PT, United Kingdom
| | - Dhifaf A. Jasim
- Nanomedicine
Lab, National Graphene Institute and Faculty of Biology, Medicine
& Health, The University of Manchester, Manchester, M13 9PT, United Kingdom
| | - Eric Prestat
- Department
of Materials, School of Natural Sciences, The University of Manchester, Manchester, M13 9PL, United Kingdom
| | - Neus Lozano
- Nanomedicine
Lab, National Graphene Institute and Faculty of Biology, Medicine
& Health, The University of Manchester, Manchester, M13 9PT, United Kingdom
- Catalan
Institute of Nanoscience and Nanotechnology (ICN2), Barcelona, 08193, Spain
| | - Irene de Lazaro
- Nanomedicine
Lab, National Graphene Institute and Faculty of Biology, Medicine
& Health, The University of Manchester, Manchester, M13 9PT, United Kingdom
| | - Yein Nam
- Nanomedicine
Lab, National Graphene Institute and Faculty of Biology, Medicine
& Health, The University of Manchester, Manchester, M13 9PT, United Kingdom
| | - Bakri M. Assas
- Lydia
Becker Institute of Immunology and Inflammation, and Division of Infection,
Immunity and Respiratory Medicine, School of Biological Sciences,
Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, M13 9PT, United Kingdom
- Department
of Immunology, Faculty of Applied Sciences, King Abdulaziz University, Jeddah, 21589, Saudi Arabia
| | - Joanne Pennock
- Lydia
Becker Institute of Immunology and Inflammation, and Division of Infection,
Immunity and Respiratory Medicine, School of Biological Sciences,
Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, M13 9PT, United Kingdom
| | - Sarah J. Haigh
- Department
of Materials, School of Natural Sciences, The University of Manchester, Manchester, M13 9PL, United Kingdom
| | - Cyrill Bussy
- Nanomedicine
Lab, National Graphene Institute and Faculty of Biology, Medicine
& Health, The University of Manchester, Manchester, M13 9PT, United Kingdom
| | - Kostas Kostarelos
- Nanomedicine
Lab, National Graphene Institute and Faculty of Biology, Medicine
& Health, The University of Manchester, Manchester, M13 9PT, United Kingdom
- Catalan
Institute of Nanoscience and Nanotechnology (ICN2), Barcelona, 08193, Spain
| |
Collapse
|
50
|
Peng G, Montenegro MF, Ntola CNM, Vranic S, Kostarelos K, Vogt C, Toprak MS, Duan T, Leifer K, Bräutigam L, Lundberg JO, Fadeel B. Nitric oxide-dependent biodegradation of graphene oxide reduces inflammation in the gastrointestinal tract. Nanoscale 2020; 12:16730-16737. [PMID: 32785315 DOI: 10.1039/d0nr03675g] [Citation(s) in RCA: 13] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/11/2023]
Abstract
Understanding the biological fate of graphene-based materials such as graphene oxide (GO) is crucial to assess adverse effects following intentional or inadvertent exposure. Here we provide first evidence of biodegradation of GO in the gastrointestinal tract using zebrafish as a model. Raman mapping was deployed to assess biodegradation. The degradation was blocked upon knockdown of nos2a encoding the inducible nitric oxide synthase (iNOS) or by pharmacological inhibition of NOS using l-NAME, demonstrating that the process was nitric oxide (NO)-dependent. NO-dependent degradation of GO was further confirmed in vitro by combining a superoxide-generating system, xanthine/xanthine oxidase (X/XO), with an NO donor (PAPA NONOate), or by simultaneously producing superoxide and NO by decomposition of SIN-1. Finally, by using the transgenic strain Tg(mpx:eGFP) to visualize the movement of neutrophils, we could show that inhibition of the degradation of GO resulted in increased neutrophil infiltration into the gastrointestinal tract, indicative of inflammation.
Collapse
Affiliation(s)
- Guotao Peng
- Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
| | - Marcelo F Montenegro
- Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden
| | - Chifundo N M Ntola
- National Graphene Institute, and Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK
| | - Sandra Vranic
- National Graphene Institute, and Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK
| | - Kostas Kostarelos
- National Graphene Institute, and Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK and Catalan Institute of Nanoscience and Nanotechnology (ICN2), Barcelona, Spain
| | - Carmen Vogt
- Department of Applied Physics, KTH Royal Institute of Technology, Stockholm, Sweden
| | - Muhammet S Toprak
- Department of Applied Physics, KTH Royal Institute of Technology, Stockholm, Sweden
| | - Tianbo Duan
- Department of Engineering Sciences, Uppsala University, Uppsala, Sweden
| | - Klaus Leifer
- Department of Engineering Sciences, Uppsala University, Uppsala, Sweden
| | - Lars Bräutigam
- Comparative Medicine, Karolinska Institutet, Stockholm, Sweden
| | - Jon O Lundberg
- Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden
| | - Bengt Fadeel
- Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
| |
Collapse
|